Enhanced thrombin generation, P-von willebrand factor, P-fibrin D-dimer and P-plasminogen activator inhibitor 1: Predictive for venous thrombosis in asparaginase-treated children (English)
National licence
- New search for: Nowak-Göttl, U.
- New search for: Wolff, J.E.A.
- New search for: Kuhn, N.
- New search for: Boos, J.
- New search for: Kehrel, B.
- New search for: Lilienweiss, V.
- New search for: Schwabe, D.
- New search for: Jürgens, H.
- New search for: Nowak-Göttl, U.
- New search for: Wolff, J.E.A.
- New search for: Kuhn, N.
- New search for: Boos, J.
- New search for: Kehrel, B.
- New search for: Lilienweiss, V.
- New search for: Schwabe, D.
- New search for: Jürgens, H.
In:
Fibrinolysis
;
8
;
63-65
;
1994
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Enhanced thrombin generation, P-von willebrand factor, P-fibrin D-dimer and P-plasminogen activator inhibitor 1: Predictive for venous thrombosis in asparaginase-treated children
-
Contributors:Nowak-Göttl, U. ( author ) / Wolff, J.E.A. ( author ) / Kuhn, N. ( author ) / Boos, J. ( author ) / Kehrel, B. ( author ) / Lilienweiss, V. ( author ) / Schwabe, D. ( author ) / Jürgens, H. ( author )
-
Published in:Fibrinolysis ; 8 ; 63-65
-
Publisher:
-
Publication date:1994-01-01
-
Size:3 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 8
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Mice release less tissue-type plasminogen activator (t-PA) and have more active clot stabilization by FXIII compared to rats which might explain their low rate of blood clot lysisvan Giezen, J.J.J. / Bouma, B.N. / Jansen, J.W.C.M. et al. | 1993
- 1
-
Constitutive synthesis of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAT-1): Conditions and therapeutic targetsKluft, C. et al. | 1994
- 1
-
Constitutive Synthesis of Tissue-Type Plasminogen Activator (t-PA) and Plasminogen Activator Inhibitor Type 1 (PAI-1): Conditions and Therapeutic TargetsKluft, C. et al. | 1994
- 1
-
Characteristics of plasminogen activation by glycosylphosphatidylinositol- and transmembrane-anchored uPAEllis, Vincent / Lee, Sung / Dichek, David A. / Dano, Keld et al. | 1994
- 1
-
Variants of r-plasminogen to unravel the mechanism of fibrin stimulated plasminogen activationHorrevoets, Anton / Fredenburgh, Jim / Smilde, Annelies / Pannekoek, Hans / Nesheim, Michael et al. | 1994
- 1
-
The effect of substituted laminin a chain-derived peptides on the activation kinetics and zymogen conformation of plasminogenSharon Stack, M. / Pizzo, Salvatore V. et al. | 1994
- 2
-
Structure-function relationships in staphylokinase as revealed by “clusteredcharge-to-alanine” mutagenesisSilence, K. / Hartmann, M. / Gührs, K.-H. / Gase, A. / Schlott, B. / Collen, D. / Lijnen, H.R. et al. | 1994
- 2
-
Identification of structural domains of plasminogen involved in the interaction with staphylokinaseLiinen, H.R. / De Cock, F. / Van Hoef, B. et al. | 1994
- 2
-
Molecular conversions of plasminogen and staphylokinase during active site formation in the staphylokinase-plasmin(ogen) complexGase, A. / Hartmann, M. / Schlott, B. et al. | 1994
- 3
-
Construction of a phage display antibody library against platelet α-granules. selection of recombinant antibodies against type 1 plasminogen activator inhibitor (PAI-1)Lang, I.M. / Jones, T.M. / Burton, D.R. / Barbas, C.F. / Schleef, R.R. et al. | 1994
- 3
-
Production of monoclonal antibodies against the plasminogen activator inhibitor-1/tissue type plasminogen activator complexDebrock, S. / Declerck, P.J. et al. | 1994
- 3
-
A one-step enzyme immunoassay (EIA) for the simultaneous determination of t-PA/PAI-1 complexes and active PAI-1 in plasmaNieuwenhuizen, W. / Laterveer, R. / Hoegee, E. et al. | 1994
- 4
-
Isolation of anti-CD91 monoclonal FAB antibodies by combinatorial immunoglobulin repertoire cloningHor, I.R. / Van den Berg, B.M.M. / Moestrup, S.K. / Pannekoek, H. / Van Zonneveld, A.J. et al. | 1994
- 4
-
Importance of assay specificity in interpretation of cross-linked fibrin degradation in patients treated with fibrinolytic agentsEisenberg, P. / Galvani, M. / Ferrini, D. / Ottani, F. / Rusticali, F. et al. | 1994
- 4
-
Generation of monoclonal antibodies against autologous proteins in gene-inactivated miceDeclerck, P.J. / Verstreken, M. / Carmeliet, P. / Collen, D. et al. | 1994
- 5
-
3-Dimensional structures of proteinases and inhibitorsBode, W. et al. | 1994
- 6
-
A model of spontaneous intracranial hemorrhage during thrombolytic therapy using spontaneously hypertensive ratsBunting, S. / Steinmetz, H. / Gillett, N. / Refino, C.J. / Badillo, J.M. / Paoni, N.F. et al. | 1994
- 6
-
In vivo modulation of the fibrinolytic system in baboons by human interleukin 6Kruithof, Egbert K.O. / Mestries, Jean Claude / Gascon, Marie Paule / Ythier, Arnaud et al. | 1994
- 6
-
Inhibition of factor XII in septic baboons attenuates activation of complement and fibrinolytic systems and reduces the release of interleukin-6Jansen, P.M. / Pixley, R.A. / Chang, A.C.K. / Brouwer, M.C. / Roem, D. / Hack, C.E. / Taylor, F.B. Jr / Colman, R.W. et al. | 1994
- 7
-
Effect of anticoagulation and inhibition of PAI-1 activity on initial pulmonary arrest and lung metastasis formation in a nude mouse model with selected clones of human fibrosarcoma HT-1080 cellsMatsuda, E. / Tsuchiya, H. / Hufnagl, P. / Zheng, X. / Wojta, J. / Binder, B.R. et al. | 1994
- 7
-
Therapy of experimental venous thrombosis by desmin 370 (D370): Evidence for the involvement of leukocytesBarbanti, M. / Calanni, F. / Marchi, E. / Semeraro, N. / Colucci, M. et al. | 1994
- 7
-
Formation of tPA:PAI1 complex does not mediate rapid clearance of physiologic levels of tPA in vivoNguuyen, H. / Berleau, L. / Modi, N. / Bennett, W.F. / Keyt, B.A. et al. | 1994
- 8
-
Profibrinolytic functions of α-enolaseMiles, L.A. / Fowler, B.J. et al. | 1994
- 8
-
Purification and caracterization of a plasminogen binding protein from haemophilus influenzaeSjöström, I. / Netrd, C. / Ullberg, M. / Kronvall, G. / Wiman, B. et al. | 1994
- 8
-
Acute release of tissue-type plasminogen activator (t-PA) from the endothelium; regulatory mechanisms and therapeutic targetSchrauwen, Y. / de Vries, R.E.M. / Kooistra, T. / Emeis, J.J. et al. | 1994
- 8
-
Serum carboxypeptidases are regulators of the assembly of the fibrinolytic system on cell surfacesRedlitz, Alexander / Plow, Edward F. et al. | 1994
- 9
-
Urokinase and its complex with plasminogen activator inhibitor-3/protein C inhibitor in urinede Munk, G.A.W. / Jie, A.F.H. / Dooijewaard, G. / Rijken, D.C. et al. | 1993
- 9
-
Promotion of urokinase activity by cells is not dependent on the presence of urokinase receptorMerton, R.E. / Felez, J. / Fabregas, P. / Longstaff, C. et al. | 1994
- 9
-
Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalene sulphonate: Evidence for a hydrophobic binding site exposed only on the intact receptorPloug, Michael / Ellis, Vincent / Dane, Keld et al. | 1994
- 9
-
Identification of specific receptor for tissue-type plasminogen activator expressed in human endothelial cellsFukao, H. / Hagiya, Y. / Matsumoto, H. / Okada, K. / Ueshima, S. / Matsuo, O. et al. | 1994
- 10
-
Structure/function studies of tissue type plasminogen activator (t-PA)Madison, E.L. et al. | 1994
- 10
-
Phage display technology and its application to structure/function analysisBarbas, C.F. et al. | 1994
- 10
-
Thrombolysis in venous thrombosis and pulmonary embolismTurpie, A.G.G. et al. | 1994
- 11
-
Significance of exon-shuffling in the evolution of extracellular proteolytic systemsPatthy, L. et al. | 1994
- 11
-
Intramolecular domain-domain interactions in tPA and tPA/Uk chimeric moleculesNovokhatnv, V. / Medved, L. / Lijnen, H.R. / Collen, D. / Ingham, K. et al. | 1994
- 11
-
In trans complementation of the finger and the kringle-2 domain of t-PAStringer, H.A.R. / van Swieten, P. / Horrevoets, A.J.G. / Smilde, A. / Pannekoek, H. et al. | 1994
- 12
-
A single amino acid substitution Asn 22 TYR in the growth factor domain of u-PA inhibits the binding to its receptor u-PARLansink, M. / Ouax, P.H.A. / Bakker, A.H.F. / Verheijen, J.H. et al. | 1994
- 12
-
Single chain urokinase type plasminogen activator (SCU-PA) complexes with and is inhibited by plasminogen activator inhibitor type 1 (PAI-1)Manchanda, N. / Schwartz, B.S. et al. | 1994
- 12
-
Comparison of the interaction of tissue type plasminogen activator and recombinant plasminogen activator (r-PA/BM 06.022) with human umbilical vein endothelial cellsMulder, M. / Kohnert, U. / Fischer, S. / Verheijen, J.H. et al. | 1994
- 13
-
Effects of diet and exercise upon fibrinolytic activity. the oslo diet and exercise studyHaaland, A. / Anderssen, S. / Holm, I. / Hjermann, I. / Urdal, P. et al. | 1994
- 13
-
Application of the perfused-forearm model to study release mechanisms of tissue-type plasminogen activator in manJem, C. / Selin, L. / Jem, S. et al. | 1994
- 13
-
The urokinase-type, rather than the tissue-type plasminogen system is influenced by regular physical trainingHuisveld, I.A. / van den Burg, P.J.M. / van Vliet, M. / Hospers, J.E.H. / Mosterd, W.L. et al. | 1994
- 13
-
The circulatory regulation of t-PA and u-PA during exercise and alpha and beta-adrenergic agonist infusionsChandler, W.L. / Levy, W.C. / Stratton, J.R. et al. | 1994
- 14
-
Study of coagulation fibrinolysis balance inhuman hyperlipidemia = contribution of factor VIIa in extrinsic hypercoagulabilityBara, L. / Zitoun, D. / Bloch, M.F. / Basdevant, A. / Samama, M. et al. | 1994
- 14
-
Blood fibrinolytic system and lipoprotein (a) during childhood and adolescenceKeber, I. / Uršič-Bratina, N. / Stegnar, M. / Keber, D. et al. | 1994
- 14
-
In vivo release of tissue-type plasminogen activator in response to mental stressJern, Christina / Selin, Lena / Jern, Sverker et al. | 1994
- 15
-
Regulation of plasminogen activator inhibitor-1 (PAI-1) gene expression in adipose tissue and in cultured adipocytesSamad, F. / Yamamoto, K. / Roegner, K. / Loskutoff, D.J. et al. | 1994
- 15
-
Study of PAI-1 expression during endothelial cell cycleAlessi, M.C. / Fossat, C. / Hebraud, V. / Fernandez, N. / Delezay, M. / Juhan-Vague, I. et al. | 1994
- 15
-
Metabolism of type 1 plasminogen activator inhibitor (PAI-1) and vitronectin (VN) in a human megakaryocytic cell lineHill, S.A. / Joshua, P.L. / Podor, T.J. et al. | 1994
- 16
-
Relationship between insulin and IGF-1 in the up-regulation of PAI-1 synthesis in hep G2 cellsAnfosso, F. / Alessi, M.C. / Chomiki, N. / Nalbone, G. / Juhan-Vague, I. et al. | 1994
- 16
-
Transgenic mice carrying a human t-pa promoter — lacZ reporter gene: A model for the study of pharmacological modulation of fibrinolytic potentialTheuring, F. / Kooistra, T. / Schleuning, W.-D. et al. | 1994
- 16
-
Prolonged very low calorie diet in obese subjects reduces factor VII and PAI but not fibrinogen levelsPalareti, G. / Legnani, C. / Poggi, M. / Parenti, M. / Babini, A.C. / Biagi, R. / Baraldi, L. / Luchi, A. / Capelli, M. / Coccheri, S. et al. | 1993
- 16
-
Angiotensin increases plasminogen activator inhibitor activity and MRNA in cultured rat vascular smooth muscle cellsvan Leeuwen, René / Kol, Amir / Kluft, Cornelis / Sperti, Giovanni et al. | 1994
- 16
-
Cytokine regulation of type-1 plasminogen activator-inhibitor in human hepatocytes in vivo and in human hepatoma cells in vitroGelehrter, T.D. / Healy, A.M. / Thornton, A.J. et al. | 1994
- 17
-
Conformational studies on forms of plasminogen activator inhibitor, PAI-1Sancho, E. / Declerck, P.J. / Price, N. / Kelly, S.M. / Haris, P.I. / Chapman, D. / Booth, N.A. et al. | 1994
- 17
-
The structural basis of latency in PAI-1Tucker, H.M. / Mottonen, J. / Goldsmith, E.J. / Gerard, R.D. et al. | 1994
- 17
-
Analysis of plasminogen activator inhibitor type 1 (PAI-1) by light spectroscopyFa, M. / Aleshkov, S. / Strandberg, L. / Karolin, J. / Johansson, L.B-Å. / Ny, T. et al. | 1994
- 18
-
Phage display to study the interaction of PAI-1 with the VR-1 region of t-PAVan Meiier, M. / Roelofs, Y. / Klein Gebbink, R. / van Zonneveld, A.J / Pannekoek, H. et al. | 1994
- 18
-
PAI-1 Binds exclusively to the protease domain of tPABjörquist, P. / Brohlin, M. / Ehnebom, J. / Ericsson, M. / Kristiansen, C. / Pohl, G. / Denium, J. et al. | 1994
- 18
-
Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive site loopDeclerck, P.J. / Audenaert, A.M. / Knockaert, I. / Collen, D. et al. | 1994
- 19
-
Plasminogen activator regulation studies following transfection of human endothelial cellsHanemaaijer, R. / Arts, J. / le Clercq, L. / Kooistm, T. / van Hinsbergh, V. et al. | 1994
- 19
-
Fibrinolytic activity is not impaired in regular smokers and snuff dippers — the Northern Sweden Monica studyEliasson, M. / Asplund, K. / Evrin, P.-E. / Lundblad, D. et al. | 1994
- 19
-
Familial dysfibrinogenemia and thrombophilia. Structural defects and impaired fibrinolysisHaverkate, F. / Samama, M.M. et al. | 1994
- 19
-
Epidemiology of plasma D-dimer, tPA and Von Willebrand factor antigens: Glasgow Monica studyLowe, G.D.O. / Rumley, A. / Lee, A.J. / Tunstall-Pedoe, H.D. et al. | 1994
- 20
-
Fibrinolytic anomalies associated with insulin resistance. Effect of metformin. Results of the Bigpro trialJuhan-Vague, I. / Aillaud, M.F. / Alessi, M.C. / Vague, P. / Rudnichi, A. / Safar, M. / Bard, J.M. / Fontbonne, A. / Eschwege, E. et al. | 1994
- 20
-
Biovariability over a 24 week period in plasminogen activator inhibitor-1 levelsMacy, E.M. / Hayes, T.E. / Tracy, R.P. / Bovill, E.G. et al. | 1994
- 20
-
Abnormally high fibrinolytic variables in survivors of ischemic strokeMargaglione, Maurizio / Grandone, Elvira / Vecchione, Gennaro / Cappucci, Giuseppe / Di Minno, Giovanni et al. | 1994
- 21
-
Enhancement of endogenous rat plasma tissue-type plasminogen activator antigen and activity by cAMP-enhancing compoundsEmeis, J.J. / de Vries, R.E.M. / Schrauwen, Y. / Kooistra, T. et al. | 1994
- 21
-
Identification of genomic sequences involved in the induction of human t-PA gene expression by steroid hormones and retinoic acidBulens, F. / Van Acker, P. / Belayew, A. / Collen, D. et al. | 1994
- 21
-
Retinoids stimulate t-PA synthesis in cultered human endothelial cells by a hitherto unknown two-stage mechanismLansink, Mirian / Toet, Karin / Kooistra, Teake et al. | 1994
- 22
-
The effect of the relationship between tissue-type plasminogen activator and plasminogen activator inhibitor type 1 on tissue-type plasminogen activator activity in insulin-dependent diabetes mellitusMyrup, B. / Rossing, P. / Jensen, T. / Gram, J. / Kluft, C. / Jespersen, J. et al. | 1994
- 22
-
Plasminogen activators in bovine milk during mastitis, an inflammatory diseaseHeegaard, C.W. / Christensen, T. / Rasmussen, M.D. / Benfeldt, C. / Jensen, N.E. / Sejrsen, K. / Petersen, T.E. / Andreasen, P.A. et al. | 1993
- 22
-
Transcriptional regulation of the rat tissue-type plasminogen activator (tPA) geneLeonardsson, G. / Ohlsson, M. / Ny, T. et al. | 1994
- 22
-
Chromatin structure of the human urokinase-type plasminogen activator geneIbanez-Tallonl, Ines / Blasil, Francesco / Crippal, Massimo P. et al. | 1994
- 22
-
Antisense oligonucleotides to transcription factor NFκB suppress urokinase secretion in an ovarian carcinoma cell line while leaving plasminogen activator inhibitor type-1 expression unaffectedReuning, U. / Wilhelm, O. / Schmitt, M. / Graeff, H. et al. | 1994
- 23
-
The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasionDano, K. / Behrendt, N. / Briinner, N. / Ellis, V. / Grondahl-Hansen, J. / Nielsen, B.S. / Pappot, H. / Ploug, M. / Pyke, C. / Rømer, J. et al. | 1994
- 23
-
The urokinase receptorVassali, J.-D. et al. | 1994
- 23
-
Structure, function, localization and regulation of the upa receptor, uPARBlasi, Francesco / Conese, Massimo / Fazioli, Francesca / Grebe, Alexandra / Limongi, Paola / Resnati, Massimo / Riittinen, Leena / Sidenius, Nicolai / Soravia, Emilia / Talarico, Daniela et al. | 1994
- 24
-
Carboxypeptidase U : A novel plasma carboxypeptidase with affinity for plasminogenHendriks, D. / Wang, W. / Scharpe, S. et al. | 1994
- 24
-
Two-chain urokinase inactivates human α-thrombinde Raucourt, E. / Miyata, T. / Anglés-Cano, E. / Guillin, M.C. / Bezeaud, A. et al. | 1994
- 24
-
Demonstration of covalent binding of lipoprotein(A) [Lp(a)] to fibrin and human umbilical vein endothelial cells (HUVEC)Liu, J. / Gurewich, V. et al. | 1994
- 25
-
Non-esterified fatty acids are related with hypofibrinolysis in type 2 diabetes mellitusBrussaard, H.E. / Gevers Leuven, J.A. / Krans, H.M.J. / Meijer, P. / Buytenhek, R. / Kluft, C. et al. | 1994
- 25
-
Thrombospondin 1 as a regulator of neutrophil enzyme-mediated extracellular matrix proteolysisHood, Philip J. / Chesterman, Colin N. et al. | 1994
- 26
-
Endotoxin-induced activation and inhibition of febrinolysis: Effects of various interventions in the cytokine and coagulation cascades in experimental endotoxemia in chimpanzeesLevi, M. / Biemond, B.J. / ten Cate, H. / van der Poll, T. / Hack, C.E. / ten Cate, J.W. et al. | 1994
- 26
-
Interspecies scaling of WT-tPA and TNK-tPA: Prediction of tnk-tpa clearance in humansBerleau, L. / Refino, C.J. / Modi, N. / Bennett, W.F. / Keyt, B.A. et al. | 1994
- 26
-
Reduced hepatic clearance of tissue type plasminogen activator (1-PA) is a key determinant of increased fibrinolytic activity during exerciseFras, Z. / Keber, D. et al. | 1994
- 27
-
Cell activation and fibrinolysis with regard to severity of illness and organ failure in septic patientsLeahäauser, B. / Matthias, F.R. / Dooiiewaard, G. et al. | 1994
- 28
-
Plasminogen activator inhibitor 1 (PAI-1) gene expression in human megacaryocytesAlessi, M.C. / Chomiki, N. / Fossat, C. / Berthier, R. / Juhan-Vague, I. et al. | 1994
- 28
-
Translocation of plasminogen activator inhibitor type 2 in vivo: High expression levels result in intracellular polymerisationMikus, P. / Ny, T. et al. | 1994
- 28
-
Molecular characteristics of human plasma, platelet and vascular cell PAI-1. Comparison between normal and thrombocytemic subjectsPannocchia, A. / Garis, G. / Giorgianni, A. / Stella, S. / Pileri, A. / Bazzan, M. et al. | 1994
- 28
-
Glycoprotein 330 and low density lipoprotein receptor-related protein mediate internalization of prourokinase and complexes of urokinase with pai-1 in type II pneumocytesKounnas, M.Z. / Stefansson, S. / Strickland, D.K. / Argraves, W.S. et al. | 1994
- 29
-
Modulation of urokinase synthesis by deferoxamine mesylate in human cerebral microvascular endothelial cellsDoherty, J.M. / Orfeo, T. / Shatos, M.A. et al. | 1994
- 30
-
In vitro binding of free and liposomal gluplasminogen to fibrinHeeremans, J.L.M. / Prevost, R. / Lose, P. / Kluft, C. / Crommelint, D.J.A. et al. | 1994
- 30
-
Analysis of kinetic and thermodynamic parameters of isolated plasminogen 2 glycoformsPirie-Shepherd, Steven R. / Pizzo, Salvatore V. et al. | 1994
- 30
-
Stopped-flow fluorescence kinetics of the reaction of inhibitor with plasminBangert, K. / Thorsen, S. / Christensen, U. et al. | 1994
- 31
-
Introduction of a lysine binding kringle in u-PA does not result in lysine binding and fibrin-dependent plasminogen activationBakker, A.H.F. / Verheijen, J.H. et al. | 1994
- 31
-
Characterization of the oligosaccharide structures on a recombinant tissue-type plasminogen activator analog synthesized in chinese hamster ovary cellsAeed, P.A. / Guido, D.M. / Mathews, W.R. / Leone, J.W. / Elhammer, Å.P. et al. | 1993
- 31
-
Correlation Between ECLT, t-PA and PAI-1 Activity and Antigen Levels in Healthy VolunteersDavid, M. / Losonczy, H. et al. | 1994
- 31
-
Correlation between ECLT, t-PA and PAM activity and antigen levels in healthy volunteersDávid, M. / Losonczy, H. et al. | 1994
- 31
-
In vitro stability of the recombinant plasminogen activator BM 06.022 in human plasmaRijken, D.C. / Groeneveld, E. / Barrett-Bergshoeff, M.M. et al. | 1994
- 31
-
Active site labelling with dansyl-glutamayl-glycyl-arginyl chloromethyl ketone demonstrates the full activity of the refolded and purified tissue-type plasminogen activator variant BM 06.022Kohnert, Ulrich / Wozny, Manfred / Llinas, Manuel / Roos, Anita / Fischer, Stephan et al. | 1994
- 32
-
Phosphorylation of plasminogen activatorsBarlati, S. / Bona, C. / De Petro, G. et al. | 1994
- 32
-
New aspects of the interaction between staphylokinase and plasminogenGuehrs, K.-H. / Birch-Hirschfeld, E. / Gase, A. / Hartmann, M. / Schlott, B. et al. | 1994
- 32
-
Characterization of the Oligossaccharide Structures on a Recombinant Tissue-type Plasminogen Activator Analog Synthesized in Chinese Hamster Ovary CellsAeed, P. A. / Guido, D. M. / Mathews, W. R. / Leone, J. W. et al. | 1994
- 32
-
Construction and functional analysis of staphylokinase variantsUeshima, S. / Okada, K. / Hagiya, Y. / Matsumoto, H. / Yuasa, H. / Nonaka, T. / Fukao, H. / Matsuo, O. et al. | 1994
- 33
-
Sorption of acyl-plasminogen∗streptokinase activator complex to clot and fibrinolysis in vitroAisina, R.B. / Jitkova, J.V. / Varfolomevev, S.D. et al. | 1994
- 33
-
Changes of esterase and fibrinolytic activities of plasminogen∗streptokinase activator complex in various conditionsAisina, R.B. / Sazonova, I.Y. / Muhametova, L.I. et al. | 1994
- 33
-
Role of the lysine binding sites of K4 and K5 kringles in dissolving of the fibrin clot structureAndrianov, S.A. / Makogonenko, E.M. / Kudinov, S.A. et al. | 1994
- 34
-
Relationship of plasminogen activator inhibitor activity and tissue-type plasminogen activator concentration with age, sex, risk factors for coronary heart disease and life styleSiegert, G. / Bergmann, S. / Jaross, W. et al. | 1994
- 34
-
Single chain urinary-type plasminogen activator (prourokinase) is activated by human mast cell tryptaseSharon Stack, M. / Johnson, David A. et al. | 1994
- 34
-
Fibronectin cleavage by tissue-type plasminogen activator: Comparison with urokinaseMarchina, E. / Barlati, S. et al. | 1994
- 34
-
Interaction of urinary-type plasminogen activator with extracellular matrix proteins: Specific binding to vitronectinMoser, Tammy L. / Enghild, Jan J. / Pizzo, Salvatore V. / Sharon Stack, M. et al. | 1994
- 35
-
Plasminogen activator activity of human endothelial cells induced by nonenzyme fractions of earthworm powderSumi, H. / Kitagawa, M. / Okumura, K. et al. | 1994
- 35
-
Mouse hemangioma endothelial cell cytotoxicity induced by human plasminogenDubois-Strinofellow, N. / Bautch, V.L. / Pizzo, S.M. / Gonzalez-Gronow, M. et al. | 1994
- 35
-
The changes of plasminogen activator activity during the differentiation of piglets bone marrow cellsSnitynsyky, V. / Kusen, S. / Antonyak, G. / Solohub, L. et al. | 1994
- 36
-
Molecular abnormalities of human plasminogen isolated from synovial fluid of rheumatoid arthritis patientsShearin, T. / Pizzo, S.V. / Gonzalez-Gronow, M. et al. | 1994
- 36
-
The effects of contrast media (CM) on the fibrinolytic system in an in vitro model. Possible consequences in local arterial thrombolysisBrosstad, F. / Schilvold, A. / Bjømsen, S. et al. | 1994
- 37
-
Fibrin aggregation. early protofibril formation and its interactions with other components of haemostasisEdgell, T.A. / Gaffney, P.J. et al. | 1994
- 37
-
Single step ultrarapid preparation of high purity chains of human fibrinogenRaut, S. / Corran, P.H. / Gaffney, P.J. et al. | 1994
- 37
-
Introduction to diet and endogenous fibrinolysisMarckmann, P. / Jespersen, J. et al. | 1994
- 37
-
Fibrin aggregation. The effect of a fibrin specific monoclonal antibody on the aggregation processEdgell, T. / Gaffnev, P.J. / Hockley, D. / Webbon, P. / Walker, J. et al. | 1994
- 38
-
Construction, expression and preliminary characterization of glycosylation mutants of human proteinsRydzewski, A. / Long, G.L. et al. | 1994
- 38
-
LPS-stimulated, cryopreserved human monocytes (MO) convert plasma fibrinogen to fibrin and subsequently lyse the fibrin formedKierulf, P. / Øvstebø, R. / Osnes, L. / Westvik, A-B et al. | 1994
- 38
-
Studies on hementerin, a fibrinogenolytic protein isolated from the salivary complex of the leech Haementeria depressaChudzinski-Tavassi, A.M. / Kelen, E.M.A. / Sampaio, C.A.M. / Bon, C. / Tome, L.Q. / Anglés-Cano, E. et al. | 1994
- 39
-
Antithrombotic activity of bifunctional antibodies conjugate to urokinase-type plasminogen activator (u-PA)/collagen: Lack of u-PA potentiating effectDomogatsky, S.P. / Stepanova, I.P. / Bashkov, G.V. et al. | 1994
- 39
-
Circulatinganticoagulant against human plasma prekallikrein in multiple myelomaYonekawa, Osamu / Hamada, Etsuko / Ohno, Ryuzo / Kanno, Takashi et al. | 1994
- 39
-
Comparative model building of plasma carboxypeptidase UHendriks, D. / Vriend, G. / Wang, W. / Scharpe, S. et al. | 1994
- 40
-
Human anti-streptokinase antibodies induce platelet aggregation in a Fc/CD32-dependent mannerLebrazi, J. / Helft, G. / Vacheron, A. / Samama, M.M. / Mirshahi, M. / Lecompte, T. et al. | 1994
- 40
-
Beneficial effects of heparin coated devices and aprotinin on blood cells and contact system activation in an in vitro cardiopulmonary bypass modelWendel, H.P. / Gallimore, M.L. / Heller, W. et al. | 1994
- 40
-
Plasma clot lysis by staphylokinase in vitro. Effects on coagulation and plateletsHauutmann, J. / Stebani, I. / Glusa, E. et al. | 1994
- 41
-
The effect of fasting and/or body weight reduction on tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1)Petemel, P. / Stegnar, M. / Mavri, A. / Salobir-Pajnič, B. et al. | 1994
- 41
-
Strenuous physical exercise is associated with a dissociation in coagulant and fibrinolytic balance during recoveryvan den Burg, P.J.M. / van Vliet, M. / Hosers, J.E.H. / Mosterd, W.L. / Huisveld, I.A. et al. | 1994
- 41
-
Lipid-related hemostatic abnormalities in the elderly: Imbalance between coagulation and fibrinolysisMatsuo, T. / Kario, K. / Koide, M. et al. | 1994
- 41
-
Plasmin formation, not prothrombin activation, leads to enhanced thrombin levels during physical exerciseHuisveld, I.A. / van den Burg, PJM / van Vliet, M. / Hospers, J.E.H. / Mosterd, W.L. et al. | 1994
- 42
-
Granulocyte-macrophage colony-stimulating factor (GM-CSF) increases plasma fibrinolytic activity in vivoYong, K.L. / McNally, T. / Mackie, I.J. / Cohen, H. / Machin, S.J. / Linch, D.C. et al. | 1993
- 42
-
Coagulation and fibrinolysis in patients with Crohn's diseaseMeriane, F. / Yahya, S. / Djeha, N. / Zerhouni, L. / Abdelaziz, R. / Badereddine, L. et al. | 1994
- 43
-
The level of pi.asminogen activator inhibitor of type 1 (PAI-1) and type 2 (PAI-2) in plasma and amniotic fluid before labour and after childbirthUszyński, M. / Kotschy, M. / Uszyński, W. / Jurkowski, P. / Kiełkowski, A. et al. | 1994
- 43
-
Release of tissue-type plasminogen activator in response to muscarinic receptor stimulation and shear stressJern, Christina / Selin, Lena / Bergbrant, Anders / Jern, Sverker et al. | 1994
- 43
-
In vitro whole blood clot lysis by rt-PA is inversely correlated with baseline plasma levels of t-PA antigenColucci, M. / Scopece, S. / Gelato, A. / Cavallo, L.G. / Semeraro, N. et al. | 1994
- 44
-
No increase in PAI-1 levels after medium-term n-3 pufa ethyl ester supplementation in healthy subjectsPrisco, D. / Paniccia, R. / Filippini, M. / Francalanci, I. / Bandinelli, B. / Brunelli, T. / Comeglio, P. / Zarone, N. et al. | 1994
- 44
-
The effect of oat husk supplementation in diet on plasminogen activator inhibitor type 1 in diabetic survivors of myocardial infarctionGužič, B. / Sundell, I.B. / Keber, I. / Keber, D. et al. | 1994
- 44
-
Biological variation of PAI-1 and proteins S activities in healthy subjectTrotti, R. / Ferri, C. / Magistroni, S. / Melzi d'Eril, G.V. et al. | 1994
- 44
-
Body composition and plasma PAI-1 levels, but not age, strongly predict stimulated fibrinolytic responsevan den Burg, P.J.M. / van Vliet, M. / Hosvers, J.E.H. / Mosterd, W.L. / Huisveld, I.A. et al. | 1994
- 45
-
Correlations between PAI-1, fibrinogen, factor VII, plasma viscosity levels and fat distribution measured by computer tomography in obese subjectsLegnani, C.C. / Biagi, R. / Babini, A.C. / Poggi, M. / Zanini, A. / Baraldi, L. / Ludovici, S. / Parcuti, M. / Palarcti, G. / Coccheri, S. et al. | 1994
- 45
-
Allele specific pcr for detection of a sequence polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) geneFalk, G. / Svensson, H. / Almqvist, Å. / Wiman, B. et al. | 1994
- 45
-
A monoclonal antibody specific for single-chain histidine-rich glycoprotein (HRG) does not react with an abnormal hrg variant (hrg Eindhoven)van Boheemen, P.A. / Keesmaat, P.S. / Hennis, B.C. / Hoffmann, J.J.M.L. / Slappendel, S.L.G. / Doojewaard, G. / Kluft, C. et al. | 1994
- 46
-
High fibrinogen levels and degradation productsConkie, J.A. / Graham, A. / McCall, F. / Walker, I.D. et al. | 1994
- 46
-
The value of plasma D-dimer in the exclusion of suspected pulmonary embolismvan Beek, E.J.R. / van den Ende, A. / Brandies, D.P.M. / Bossuyt, P.M.M. / Büller, H.R. et al. | 1994
- 46
-
Predictive value of fibrin degradation products in pulmonary thromboembolismGarcia Frade, L.J. / Flores, J. / Lancha, C. / Ulibarrena, C. / Perez Rodriguez, E. / Rueda, M.D. / Garcia Avello, A. et al. | 1994
- 47
-
Prolonged tissue plasminogen activator (t-PA) half life and increased hepatic extraction ratio for t-PA during physical activityFras, Z. / Keb, D. et al. | 1994
- 47
-
Endurance training enhances fibrinolysis in older men and women by different mechanismsChandler, W.L. / Schwartz, R.S. / Stratton, J.R. / Vitiello, M.V. et al. | 1994
- 47
-
PADMA-28, a botanical compound, decreases the oxidative burst response of monocytes and improves fibrinolysis in patients with stable intermittent claudicationWinther, K. / Kharazmi, A. / Himmelstrup, H. / Drabaek, H. / Mehlsen, J. et al. | 1994
- 47
-
Results of an activated microtitre clot lysis assay in plasma from individuals with hypo-ldysplasminogenemia and dysribrinogenemiaSchoeppach, H. / Mondorf, W. / Kuhnt, R. / Reitz, H. / Stoll, H. / Zwinge, B. / Scharrer, I. et al. | 1994
- 48
-
Blood coagulation and fibrinolytic factors are unchanged by aerobic exercise or fat modified diet Randomized clinical trial in middle-aged menRankinen, T. / Rauramaa, R. / Väisänen, S. / Halonen, P. / Penttilä, I.M. et al. | 1993
- 48
-
Correlation of fibrinolytic variables with the presence and extent of peripheral atherosclerotic diseaseRumley, A. / Woodburn, K.R. / Lowe, G.D.O. / Pollock, J.G. et al. | 1994
- 48
-
Elevated LDL may contribute to increased requirement for heparin in pts with AMIGórski, J. / Słonecka, A. / Flasiński, J. / Wasilewska, A. / Winnicka, A. / Kurek, P. / Dmochowska, W. et al. | 1994
- 48
-
Polymorphisms of the apolipoprotein(a) gene in patients with cerebral thrombosisIchinose, Akitada / Suzuki, Koji / Hashiauchi, Teruto / Kuriyama, Masaru et al. | 1994
- 49
-
Plasma retinol — A predictor of low fibrinolytic activity? The Northern Sweden Monica studyEliasson, M. / Evrin, P.-E. / Huhtasaari, F. / Johansson, I. et al. | 1994
- 49
-
Familial thrombophilia, hypofibrinolysis, and high lipoprotein(a): Pathophysiologic etiologies of legg-perthesGlueck, C.J. / Crawford, A. / Roy, D. / Freiberg, R. / Glueck, H.I. / Kahn, A. / Hamer, T. / Tracy, T. / Stroop, D.M. et al. | 1994
- 49
-
t-PA and family history of thrombosis in AMI patients from gissi trial : Biochemical and genetic aspectsIacoviello, L. / De Knijff, P. / Amore, C. / Klufl, C. / Donati, M.B. et al. | 1994
- 50
-
The tight association of endogenous and exogenous pro-urokinase (PRO-UK) with human plateletsPannell, R. / Johnstone, M. / Gurewich, V. et al. | 1994
- 50
-
Effect of fish oil and vitamin E on the cardiovascular risk indicators fibrinogen, C-reactive protein and PAI activity in healthy young volunteersde Maat, M.P.M. / Princen, H.M.G. / Dagneli, P.C. / Kamerling, S.W.A. / Kluft, C. et al. | 1994
- 50
-
Structural similarity between uPAR, other proteins of the Ly-6 family and snake venom α-neurotoxinsEllis, Vincent / Ploug, Michael / Dane, Keld et al. | 1994
- 50
-
Subcellular localization of urokinase-type plasminogen activator and its receptor on normal and PNH-affected neutrophilsPedersen, T.L. / Kjeldsen, L. / Plesner, T. / Sengeløv, H. / Rorregaard, N. / Rønne, E. / Grøndahl-Hansen, J. / Danø, K. / Hansen, N.E. et al. | 1994
- 51
-
Inactivation of the mouse urokinase-receptor geneDewerchin, M. / Carmeliet, P. / Van Nuffelen, A. / Collen, D. / Mulligan, R.C. et al. | 1994
- 51
-
Natural and non-glycosylated recombinant urokinase-type plasminogen activator are recognized by different receptor systems in the rat livervan der Kaaden, M.E. / Rijken, D.C. / Groeneveld, E. / van Berkel, Th.J.C. / Kuiper, J. et al. | 1994
- 51
-
Urokinase receptor (uPAR) expression during hematopoietic maturationJardí, M. / Ingles-Esteve, J. / Fábregas, P. / Azqueta, C. / Velasco, F. / Félez, J. et al. | 1994
- 52
-
Investigation of whole cells as promoters of tPA activitySinniger, V. / Merton, R.E. / Longstaff, C. et al. | 1994
- 52
-
Receptor-mediated inhibitor-dependent catabolism of tissue type and urokinase plasminogen activator by hep G2 cells is distinct from other characterised receptor systemGrimsley, P.G. / Normyle, J.F. / Brandt, R.A. / Joulianos, G. / Chesterman, C.N. / Hogg, P.J. / Owensby, D.A. et al. | 1994
- 52
-
The binding of tissue plasminogen activator (tPA) to endothelial cells is largely mediated by a ligand in the b-chain. the activity is stimulated and protected against inhibitionWallén, P. / Chena, X.-F. / Brohlin, M. / Pohl, G. / Bäck, O. et al. | 1994
- 53
-
The stimulating effect of acetyl low density lipoproteins on PAI-1 in endothelial cells is mediated by the scavenger receptorMussoni, L. / Banfi, C. / Baldassarre, D. / Camera, M. / Prati, L. / Tremoli, E. et al. | 1994
- 53
-
Role of the cell surface fibrinolytic system in processing of the chromaffin granule protein, chromogranin a (CgA)Parmer, R.J. / O'Connor, D.T. / Miles, L.A. et al. | 1994
- 53
-
Changes in acute release of t-PA after chronic administration of n-3 polyunsaturated fatty acids into rabbitsPetrukhina, G.N. / Gandel, V.H. / Makarov, V.A. / Bashkov, G.V. et al. | 1994
- 53
-
The use of endothelial cell plasma membrane vesicles for the study of fibrinolytic enzyme kinetics at the endothelial cell surfaceZoellner, H. / Beckmann, R. / Binder, B.R. et al. | 1994
- 54
-
Generation and characterization of monoclonal antibodies against plasmin receptor from human carcinoma cellsLopez-Alemany, R. / Mirshahi, F. / Burtin, P. / Soria, C. / Soria, N. / Faure, J.P. / Mirshahi, M. et al. | 1994
- 54
-
Effects of Fish Oil Supplementation in Late Pregnancy on Blood Lipids, Serum Urate, Coagulation and Fibrinolysis. A Randomised Controlled SurveySoerensen, J. D. / Olsen, S. F. / Secher, N. J. / Jespersen, J. et al. | 1994
- 54
-
Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis. A randomised controlled studySørensen, J.D. / Olsen, S.F. / Secher, N.J. / Jespersen, J. et al. | 1993
- 55
-
Plasma fibrinolytic profits in patients witii brain tumorsCarelli, E.F. / Facure, J.J. / Ribeiro, C.C. / Annichino-Bizzachi, J.M. et al. | 1994
- 55
-
An Antibody Fragment Against PAI-1 Inhibits PAI-1 Activity and Stimulates Fibrinolysis In Vitro and In VivoAbrahamsson, T. / Bjoerquist, P. / Deinum, J. / Ehnebom, J. et al. | 1994
- 55
-
Plasminogen activators and activator inhibitors in cervical cancerGonsalves, R. / Blankson, S. / Sheppard, B. / McGuinness, E. / Bonnar, J. et al. | 1994
- 55
-
An antibody ragment against PAI-1 inhibits PAI-1 activity and stimulates fibrinolysis in vitro and in vivoAbrahamsson, T. / Björquist, P. / Deinum, J. / Ehnebom, J. / Hulander, M. / Legnehed, A. / Matsson, C. / Nerme, V. / Westin-Eriksson, A. / Åkerblom, B. et al. | 1994
- 55
-
Blood fibrinolytic activity and DIC syndrome in patients 'kith acute promyelocytic leukemia (APL)Abdulkadyrov, K. / Popova, T. / Fedorova, Z. et al. | 1994
- 56
-
Increased plasma levels of urokinase type plasminogen activator during hepatocellular carcinomaHanss, M. / Bonvoisin, C. / Patouillard, B. / Martin, T. / Martin, D. / Audigier, J.C. / Descos, L. / Dechavanne, M. et al. | 1994
- 56
-
Regulation of ovarian carcinoma-associaited proteinases: Cell surface-mediated proteolysis by plasma membrane localized matrix metalloproteinase-2 and urinary-type plasminogen activatorYouna, Timothy N. / Moser, Tammy L. / Rodriguez, Gustavo C. / Bast, Robert C. Jr. / Pizzo, Salvatore V. / Stack, M.Sharon et al. | 1994
- 56
-
Recombinant PAI-2 inhibition of uPA-producing tumours in scid-miceBillström, A. / Lecander, I. / Åstedt, B. et al. | 1994
- 57
-
Immunohistologic localization of urokinase plasminogen activator and its receptor in ovarian carcinoma tissueCasslén, B. / Hägerstrand, L. / Lecander, I. / Åstedt, B. et al. | 1994
- 57
-
Analysis of UPA induced proteolytic activity in extracellular matrix of human highly metastatic lung adenocarcinoma cell lineHaqiya, Yasuhiro / Fukao, Hideharu / Matusmoto, Hiroshi / Okada, Kiyotaka / Ueshima, Shigeru / Kamiishi, Hirosi / Matsuo, Osamu et al. | 1994
- 57
-
The decrease of plasminogen activator inhibitor after normalization of triglycerides during treatment with fibratesKeber, I. / Lavre, J. / Šuc, S. / Keber, D. et al. | 1994
- 57
-
u-PA production and u-PA mediated extracellular matrix degradation by rat prostate cancer cells in vitro correlates with metastatic behaviour in vivode Bart, A.C.V. / Ouax, P.H.A. / Schalken, J.H. / Verheijen, J.H. et al. | 1994
- 58
-
Progesterone stimulates internalization and degradation of urokinase plasminogen activator by upregulating the expression of plasminogen activator inhibitor 1 and the urokinase receptor in endometrial stromal cells. Comparison of progesterone and TGFβCasslén, B. / Nordengren, L. / Gustavsson, B. / Isacsson, C. et al. | 1994
- 58
-
X-ray induction of urokinase-type plasminogen activator and collagenase-like proteinaseUchida, N. / Takahashi, K. / Kasai, T. / Kwaan, H.C. et al. | 1994
- 58
-
Image analysis of irradiated tumor cell line shows heterogeneity of uPA expressionTakahashi, K. / Uchida, N. / Kasai, T. / Kwaan, H.C. et al. | 1994
- 59
-
Growth stimulation of two human cancer cell lines by urokinaseOh, D.Y. / Kwaan, H.C. / Goolsby, C. / Verrusio, B. / Yoshida, E. / Soff, G.A. et al. | 1994
- 59
-
The decrease in cell migration of a derived ovarian carcinoma cell line with defective urokinase production and normal urokinase receptor expression is not corrected by addition of urokinase: A possible explanationMirshahi, S.S. / Soria, J. / Lu, H. / Benard, J. / PujadeLauraine, E. / Mishal, Z. / Burtin, P. / Bernadou, A. / Soria, C. et al. | 1994
- 59
-
Messenger RNA for urokinase Plasminogen Activator (uPA) in benign and malignant human breast lesions. An in situ hybridization studyNielsen, Boye Schnack / Sehested, Maxwell / Jensen, Karen / Pyke, Charles / Dano, Keld et al. | 1994
- 60
-
The effect of gliclazide on plasma urokinase-related fibrinolysis. The results from an exploratory studyGram, J. / Jespersen, J. / Dooijewaard, G. / Kluft, C. et al. | 1994
- 60
-
Quantitation of urokinase-type plasminogen activator receptor and its mRNA in tumor cell culturesIhara, H. / Urano, T. / Urano, S. / Takada, Y. / Takada, A. et al. | 1994
- 60
-
Reversion of the invasive phenotype of human fibroblasts by antimessenger oligonucleotide inhibiting the urokinase receptor gene expressionFibbi, G. / Anichini, E. / Pucci, M. / Capaccioli, S. / Del Rosso, M. / Quattrone, A. et al. | 1994
- 60
-
Differentiation of promyelocytic NB4 cells by retinoic acid is associated with a rapid increase in urokinase activity subsequently dow nregulated by production of inhibitorsTapiovaara, H. / Matikainen, S. / Hurme, M. / Vaheii, A. et al. | 1994
- 61
-
Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumorsLandau, B. / Brern, S. / Verrusio, E. / Kwaan, H. et al. | 1994
- 61
-
Effect of metoprolol on fibrinolytic activity in hypertensive patients with high plasminogen activator inhibitor activityde Vries, R.A. / Kraaijenhagen, R.J. / Freen, M. / Hart, H.Ch. et al. | 1993
- 61
-
RT-PCR detection of u-PA and t-PA mRNAs: Molecular markers for hepatocellular carcinomaTavian, D. / De Petro, G. / Mounir Nasir, N. / Portolani, N. / Giulini, S.M. / Barlati, S. et al. | 1994
- 61
-
Tissue plasminogen activator (t-PA) is increased in endometrial hyperplasia, and urokinase plasminogen activator (u-PA) is increased in endometrial carcinomaNordengren, J. / Gustavsson, B. / Casslén, B. et al. | 1994
- 62
-
Decreased protein c and elevated alpha1-antitrypsin levels in patients with breast cancer, gastric cancer and malignant melanomaWojtukiewicz, M.Z. / Bielawiec, M. / Kłozko, J. / Galar, M. / Jaromin, J. / Matuszewska, E. et al. | 1994
- 62
-
Plasminogen activators and tissue factor contents in tissular extracts of prostatic neoplasmsOliver, A. / Xabier, B. / Vicente, M. / Super, R. / Laquna, P. / Mateo, J. / Fontcuberta, J. / Vicente, J. et al. | 1994
- 62
-
Detection of fibrin in canine tumours — Its clinical relevanceMcEvoy, F.J. / Edgell, T.A. / Webbon, P.M. / Gaffney, P.J. et al. | 1994
- 63
-
Enhanced thrombin generation, P-von willebrand factor, P-fibrin D-dimer and P-plasminogen activator inhibitor 1: Predictive for venous thrombosis in asparaginase-treated childrenNowak-Göttl, U. / Wolff, J.E.A. / Kuhn, N. / Boos, J. / Kehrel, B. / Lilienweiss, V. / Schwabe, D. / Jürgens, H. et al. | 1994
- 63
-
Characterization of protein c inhibitor (PCI)-binding glycosaminoglycans (GAGs) of epithelial kidney tumor cells (TCL-598)Priglinger, U. / Geiger, M. / Bielek, E. / Vanvek, E. / Binder, B.R. et al. | 1994
- 64
-
Rellevance of the experimental antithrombotic effect with the ex vivo testing results of low molecular weight heparinsKrupiński, K. / Breddin, H.K. / Bielawiec, M. et al. | 1994
- 64
-
Effect on svate-3 on the experimental thrombosis and on the blood concentration of TXB2, 6-keto-PGF1α as well as on their ratioQu, J.-H. / Hao, W.-X. / Xu, J.-X. / Yang, J.-G. / Liu, S.-L. / Wang, D.-L. et al. | 1994
- 64
-
Antithrombotic effect of LMW and HMW dermatansulphate (DS) in a rat model of arterial thrombosisBuczko, W. / Pawlak, K. / Barbanti, M. / Iacoviello, L. / Donati, M.B. et al. | 1994
- 65
-
Notices| 1994
- 65
-
The effect of fibrinolytic agents on primary thrombus formationStassen, J.M. / Nyström, A. / Vanlinthout, I. / Moreau, H. / Hoylaerts, M. et al. | 1994
- 65
-
Thrombolytic effect of a modified plasminogen activator (SUN9216) on photochemically induced thrombosis (PIT) models in the rat femoral and middle cerebral arteryMatsuno, H. / Uematsu, T. / Takiguchi, Y. / Nakashima, M. et al. | 1994
- 65
-
Prolonged presence of DSPAα1 antigen in plasma parallels long-lasting fibrinolytic activity in rats and monkeysVerhallen, P. / Bhargava, A.S. / Bringmann, P. / Hildebrand, M. et al. | 1994
- 66
-
Antibody formation and effects on endogenous fibrinolysis after repeated administration of dspaai in ratsWitt, W. / Kirchhoff, D. / Woy, P. / Zierz, R. / Bhargava, A.S. et al. | 1994
- 66
-
Influence of two different e.coli asparaginase preparations on coagulation and fibrinolysis: A randomized trialNowak-Göttl, U. / Boos, J. / Wolff, J.E.A. / Werber, G. / Ahlke, E. / Pollmann, H. / Jürgens, H. et al. | 1994
- 66
-
Pharmacokinetics of DSPAα1 in animalsHildebrand, M. / Bhargava, A.S. / Bringmann, P. / Verhallen, P. et al. | 1994
- 66
-
Pharmacokinetics and fibrinolytic aspects of intraabdominally administered human tissue type plasminogen activator in a rat peritonitis modelBorn, V.J.J. / van Goor, H. / de Graaf, J.S. / Geerards, S. / van der Schaaf, W. / Bleichrodt, R.P. / van der Meer, J. et al. | 1994
- 67
-
Thrombolytic effects of fibrolase in a canine model of carotid artery thrombosisMarkland, F.S. / Friedrichs, G.S. / Pewitt, S.R. / Lucchesi, B.R. et al. | 1994
- 67
-
Meta-analysis of all available published clinical trials (1958–1990) on thrombolytic therapy for AMI: Relative efficacy of different therapeutic strategiesGrünewald, M. / Seifried, E. et al. | 1993
- 67
-
Therapeutic activity of desmin 370 (D370) in a rat model of pulmonary embolismColucci, M. / Punzi, G. / Sardella, L. / Semeraro, N. et al. | 1994
- 67
-
Optimal dose-regimen after treatment with recombinant prourokinase (r-ProUK) in a canine arterial thrombosis modelBurke, S.E. / Lubbers, N.L. / Nelson, R.A. / Henkin, J. et al. | 1994
- 68
-
Effects of PAI-1 inhibition on clot-lysis in endotoxin-treated ratsAbrahamsson, T. / Nerme, V. / Åkerblom, B. / Legnehed, A. / Westin Eriksson, A. et al. | 1994
- 68
-
In vitro and in vivo penetration of experimentally produced clots by monoclonal antibodiesMcEvoy, F.J. / Edgell, T.A. / Webbon, P.M. / Gaffney, P.J. et al. | 1994
- 68
-
Changes in fibrinolysis, serotonin and platelet aggregation in rats induced by foot shock and restraint stressTakada, A. / Malyszko, J. / Urano, T. / Ihara, H. / Takada, Y. et al. | 1994
- 69
-
Plasmin α 2 antiplasmin complex in three different asparaginase treatment regimens in childhood leukemiaRisseeuw-Appel, I.M. / van Bodegraven, E. / Dekker, I. / Hählen, K. et al. | 1994
- 69
-
Influence of vasopressin modified forms (MFV) on the fibrinolytic systemGrigorjeva, M. / Kalishevskaya, T. / Golubeva, M. / Kaurov, O. / Smirnova, M. et al. | 1994
- 69
-
Protein C depleted activated prothrombin complex neutralizes the bleeding associated with recombinant hirudinFareed, J. / Stuever, T. / Hoppensteadt, D. / Eschenfelder, V. / Walenga, J.M. / Pifarre, R. et al. | 1994
- 69
-
The heparin-aspirin complex action on the fibrinolysis and insular system at experimental diabetesUljanov, A.M. / Lyapina, L.A. / Tarasov, Yu.A. / Pastorova, V.E. et al. | 1994
- 70
-
Interaction between insulin, lipids and reduced fibrinolytic activity in rabbit aortic vascular cellsAl-Azhary, D.B.I. / Tawfek, N.Z. / Zhang, W.J.I. / Wojta, J.I. / Binder, B.R. et al. | 1994
- 71
-
Effects of low-molecular weight and high-molecular weight heparin on the intrinsic and extrinsic endogenous fibrinolytic systemDechend, R. / Hauck, S. / Eichhom, J. / Goedecke, W. / Praus, M. / Schulz-Menger, J. / Barthels, M. / Dietz, R. / Gulba, D.C. et al. | 1994
- 71
-
Intraoperative administration of rt-PA during a case of digital revascularizationStassen, J.M. / Gang, L. / Andréen, O. / Nyström, E. / Nyström, A. et al. | 1994
- 71
-
Tissue plasminogen activator in combination with heparin for treatment of femoral artery thrombosis in infants and childrenZenz, W. / Muntean, W. / Zobel, G. / Beitzke, A. et al. | 1994
- 71
-
Tissue plasminogen activator in the treatment of two infants with fulminant meningococcemiaZenz, W. / Muntean, W. / Zobel, G. et al. | 1994
- 72
-
Clinical observation on 293 cases of unstable angina (UA) treated with refined snake venom antithrombus enzyme (SVATE-3)Li, Y. / Feng, M. / Qin, J. / Li, Q.-M. / Hao, W.-X. et al. | 1994
- 72
-
Observation of clinical therapeutic effect of antithrombus enzyme-3 (SVATE-3) on 30 cases of acute cerebral thrombosis using digital subtraction angiography (DSA) and interventional infusion of SVATE-3Hao, W.-X. et al. | 1994
- 72
-
Local urokinase thrombolytic treatment in deep vein thrombosis (DVT)Baudo, F. / de Cataldo, F. / Caimi, T.M. / Russo, A. / Brambilla, G. / Ramnoldi, A. et al. | 1994
- 73
-
Combination of streptokinase (SK) and single-chain urokinase-type plasminogen activator (scupa) has a synergistic effect on in vitro clot lysisBashkov, G.V. / Jitkova, Y.V. / Makarov, V.A. et al. | 1994
- 73
-
Various dosages of ultrahigh steptokinase in the management for deep venous thrombosis — A multicenter studyObernosterer, A. / Lafer, M. / Pilger, E. / Carlsson, A. / Eriksson, H. / Munck, D. / Talstad, I. / Grüngreiff, K. / Anders, O. et al. | 1994
- 73
-
Partial structure and properties of lebetase, a fibrinolytic enzyme from snake venomSiigur, E. / Tōnismägi, K. / Tu, A.T. / Siigur, J. et al. | 1994
- 74
-
Recanalization of acute occlusion after percutaneous transluminal coronary angioplasty (PTCA) using a synthetic thrombin inhibitor, argatrobanMatsuo, T. / Kario, K. / Suzuki, T. / Miki, T. / Sakamoto, S. et al. | 1994
- 74
-
Streptokinase and rt-PA activate platelets by a different way: Implications on the rethrombosis rate after their administration in myocardial infarctionParise, P. / Iorio, A. / Hauert, J. / Agnelli, G. et al. | 1994
- 74
-
Strong anti-platelet aggregation and fibrinolysis-potentiating activities in mushroom extracts (Pleurotus ostreatus and Lentinus edodes)Sumi, H. / Matsubara, K. / Yatagai, C. / Ishii, K. / Fujioka, T. et al. | 1994
- 75
-
Acute t-PA releasing effect of supersulphated low molecular weight heparinsKlöcking, H.-P. et al. | 1994
- 75
-
Fibrinolytic compromise by simultaneous administration of synthetic and recombinant antithrombotic agentsFareed, J. / Callas, D. / Bajusz, S. / Bacher, P. / Iqbal, O. / Hoppensteadt, D. / Walenga, J.M. / Pifarre, R. et al. | 1994
- 75
-
Impact of r-hirudin (HBW 023) and of a synthetic analogous peptide on the balance between in vitro clot growth and t-PA mediated lysisRömisch, J. / Stöhr, H.-A. / Stüber, W. et al. | 1994
- 75
-
Fibrinolytic and hemodynamic compromise by adjunct therapeutic agents used in thrombolysis. Comparative studies with recombinant tissue factor pathway inhibitorHoppensteadt, D. / Callas, D. / Iqbal, O. / Iyer, L. / Walenga, J.M. / Pifarre, R. / Fareed, J. et al. | 1994
- 76
-
Pharmacodynamics and tolerability of DT-TX 30 SE, a novel combined TXA2/PGH2 receptor blocker and thromboxane synthetase inhibitor, in healthy volunteersNarjes, H. / Müller, T.H. / Weisenberger, H. / Kirchner, M. / Deichsel, G. et al. | 1994
- 76
-
Platelet membrane structure, glycoproteins and function after thrombolytic treatmentKiciriska, M. / Górski, J. et al. | 1994
- 76
-
Effects of captopril,metoprolol and captopril-during thrombolysis. Preliminary resultsDi Pasquale, P. / Paterna, S. / Bucca, V. / Corrao, S. / Licata, G / Pipitone, F. / Caracausi, R. / Rinciari, G. et al. | 1994
- 77
-
Effects oe captopril on endothelin release. during thrombolysis. Preliminary resultsDi Pasquale, P. / Paterna, S. / Parrinello, G. / Bucca, V. / Carausi, R. / Pipitone, F. / Licata, G. et al. | 1994
- 77
-
Intraarterial fibrinolytic parameters during local low dose streptokinase therapyKozak, M. / Šabovič, M. et al. | 1994
- 77
-
Fragmentation pattern of fibrinogen during thrombolysis in acute myocardial infarction with fibrin-specific plasmionogen activators — Detection of high molecular weight fibrinogen split productsThodel, H. / Dechend, R. / Müller, T. / Eisert, W.E. / Barthels, M. / Gulba, D.C. et al. | 1994
- 78
-
Functional heterogeneity of lipoprotein(a): Cardiovascular risk in heterozygous subjects is linked to APO(a) isoformsHervio, L. / Durlach, V. / Girard, A. / Anglés-Cano, E. et al. | 1994
- 78
-
Retinoic acid restores reduced fibrinolytic activity in vitamin A deficient rats but does not enhance fibrinolytic activity in normal ratsJansen, J.W.C.M. / van Giezen, J.J.J. / Brakkee, J.G.P. / Minkema, J. / Boon, G.D.L.A. et al. | 1994
- 78
-
Identification of a common molecular variant of histidine-rich glycoprotein with a difference of 2KD in apparent molecular weightHennis, B.C. / van Boheemen, P.A. / Kievit, P. / Dooijewaard, G. / Kluft, C. et al. | 1994
- 78
-
Abnormal plasminogen genes in patients with myocaridal infarction and venous thrombosisTsutsumi, Seiji / Sakata, Toshiyuki / Mivata, Toshiyuki / Ichinose, Akitada et al. | 1994
- 79
-
Moderate alcohol consumption has large postprandial effects on fibrinolytic factors and lipoprotein metabolismHendriks, H.F.J. / Kluft, C. / Schaafsma, G. et al. | 1994
- 79
-
Protection of scu-pa and attenuation of hypercoagulability by aprotinin in patients undergoing cardio-pulmonary bypass surgery due to contact phase inhibitionSpannagl, M. / Dietrich, W. / Schramm, W. / Dooijewaard, G. et al. | 1994
- 79
-
Functional studies of an 4G/5G polymorphism in the PAI-1 promoter region which is associated with myocardial infarction at a young ageEriksson, P. / Kallin, B. / van 't Hooft, F. / Hamsten, A. et al. | 1994
- 80
-
Characterization of a new transcription factor involved in human PAI-1 gene expressionDina, H.H. / Descheemaeker, K. / Belayew, A. / Collen, D. et al. | 1994
- 80
-
Glucocorticoid regulation of the rat plasminogen activator inhibitor-1 (PAI-1) gene in FTO-2b hepatoma cells is mediated through a complex GREBruzdzinski, C.J. / Gelehrter, T.D. et al. | 1994
- 80
-
Comparative inhibition of PAI-1 expression in human endothelial cells by modified oligodeoxynucleotidesCierniewski, C.S. / Babinska, A. / Swiatkowska, M. / Wilczxnska, M. / Okruszek, A. / Stet, W.J. et al. | 1994
- 80
-
Stable enhancement of tissue-type plasminogen activator levels in blood: Interrupted chamber hypoxia mimics effects of alpine hypoxiaBashkov, G.V. / Miftachova, N.T. / Sergeev, I.Y. / Koshelev, V.B. / Makarov, V.A. et al. | 1994
- 81
-
Identification of two repressor regions within the plasminogen activator inhibitor 2 (PAI-2) gene promoterMedcalf, Robert L. / Dear, Anthony / Ruegg, Marlies et al. | 1994
- 81
-
Cytokine regulation of the murine vitronectin gene: Identification of regulatory sequences for interleukin 6Seiffert, D. / Curriden, S.A. / Binder, B.R. / Loskutoff, D.J. et al. | 1994
- 81
-
Regulation of urokinase:PAI-1 internalization: coordinate expression of the urokinase and the α2-macroglobulin receptorsConese, M. / Cavallaro, U. / Soria, M.R. / Blasi, F. et al. | 1994
- 82
-
Inhibition of coagulation and fibrinolysis by aprotinin in patients undergoing cardio-pulmonary bypass surgerySpannagl, M. / Dietrich, W. / Schramm, W. / Dooijewaard, G. et al. | 1994
- 82
-
Low density lipoprotein receptor related protein (LRP): A multiligand receptorStrickland, Dudley K. / Kounnas, Maria Z. / Williams, Suzanne E. / Scott Argraves, W. et al. | 1994
- 83
-
Binding of glu-plasminogen to fibrin by a two sites interaction plays an essential role in fibrinolysisAnglés-Cano, E. / Solis, D. / Loyau, S. / Grailhe, P. / Diaz-Maurino, T. et al. | 1994
- 83
-
The specific roles of finger and kringle-2 domain of t-PA during in vitro fibrinolysisHorrevoets, A.J.G. / Smilde, A. / de Vries, C. / Pannekoek, H. et al. | 1994
- 83
-
Superficial accumulation of plasminogen during clot lysisSakharov, D.V. / Rijken, D.C. et al. | 1994
- 84
-
Elevated fibrinolysis in cardiopulmonary bypass is factor XII dependentChung, H.I. / Burman, J.F. / Balogun, B.A. / Lincoln, J.C.R. / Pepper, J.R. et al. | 1994
- 84
-
Inner clot fluid permeation attenuates diffusion-limitations and greatly enhances fibrinolytic ratesDiamond, S.L. / Anand, S. / Wu, J.H. et al. | 1994
- 84
-
Ultrasound accelerates transport of recombinant tissue plasminogen activator (rt-PA) into clotsFrancis, C.W. / Blinc, A. / Lee, S. / Cox, C. et al. | 1994
- 84
-
Degradation of the α-chain of fibrin by human neutrophil elastase reduces the stimulating effect of fibrin on plasminogen activationBach-Gansmo, E.T. / Halvorsen, S. / Godal, H.C. / Skjønsberg, O.H. et al. | 1994
- 85
-
Infusion of 1-desamino-8-d-arginine demonstrates that increased plasminogen activator inhibitor activity is responsible for impaired fibrinolysis in patients with ischaemic heart diseasePedersen, O.D. / Gram, J. / Bagger, H. / Keller, N. / Jespersen, J. et al. | 1994
- 85
-
Tissue plasminogen activator (tpa) in arteriolar smooth muscle cells: association with tPA inhibitor, fibrin deposition and clinical outcome in transplanted human heartsFaulk, W.P. / Labarrere, C.A. / Pitts, D. / Halbrook, H. et al. | 1994
- 85
-
Accelerated coronary artery disease in heart transplant recipients with depleted arteriolar tissue plasminogen activatorLabarrere, C.A. / Pitts, D. / Nelson, D.R. / Faulk, W.P. et al. | 1994
- 86
-
Influence of continuous infusion of prostacyclin on plasma levels of t-PA, PAI-1 and vWF in primary pulmonary hypertensionBoyer-Neumann, C. / Brenot, F. / Wolf, M. / Simonneau, G. / Duroux, P. / Meyer, D. / Anglés-Cano, E. et al. | 1994
- 86
-
Pathobiochemical implications of hyperhomocysteinemiaBlom, H.J. / van der Molen, E.F. et al. | 1994
- 86
-
Localisation and quantification of proteins of the fibrinolytic system in normal and atherosclerotic vesselsRobbie, Linda A. / Booth, Nuala A. / Brown, Paul A.J. / Croll, Alison M. / Bennett, Bruce et al. | 1994
- 86
-
Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, with and without vascular complicationsMansfield, M.W. / Stickland, M.H. / Carter, A.M. / Grant, P.J. et al. | 1994
- 87
-
Heterogeneous mechanisms responsible for reduced fibrinolytic capacity in patients with a history of venous thrombosisHadjez, J.M. / Combe, S. / Horellou, M.H. / Conard, J. / Nguyen, G. / Van Dreden, P. / Samama, M. et al. | 1993
- 87
-
Update on thrombolysisde Bono, D.P. et al. | 1994
- 87
-
Fibrinolysis and atherosclerosis: An updateHamsten, A. et al. | 1994
- 87
-
Physiological effects of inactivation of the genes encoding t-PA, u-PA and PAI-1Carmeliet, P. et al. | 1994
- 88
-
Plasmin-induced activation of human coagulation factor X: A kinetic studyJitkova, Y.V. / Kogan, A.B. / Bashkov, G.V. et al. | 1994
- 88
-
Arterial disease in hyperhomocysteinaemia and the effect of treatment: A pilot studyvan den Berg, M. / Stehouwer, C.D.A. / Boers, G.H.J. / Rauwerda, J.A. / Kluft, C. et al. | 1994
- 88
-
Binding of factor Xa to fibrinogen, fibrin and fibrin degradation products (FDP): its comparison with thrombin bindingIino, M. / Takemitsu, T. / Takeya, H. / Suzuki, K. et al. | 1994
- 88
-
Inhibition of factor Xa attenuates increases in thrombin activity induced by pharmacologic plasminogen activationEwald, G. / Eisenberg, P. et al. | 1994
- 89
-
Assembly and interaction of prekallikrein (PK) and pro-urokinase (pro-UK) on human endothelial cells (ec)Lenich, C. / Pannell, R. / Gurewich, V. et al. | 1994
- 89
-
Influence of vascular smooth muscle cell conditioned media on tissue factor activity in human umbilical vein endothelial cellsZhang, J.C. / Wojta, J. / Binder, B.R. et al. | 1994
- 89
-
Activated human protein c (aPC) protects mice from thrombin-induced thromboembolism via inhibition of endogenous thrombin formation rather than via stimulation of fibrinolysisGresele, P. / Momi, S. / Berrettini, M. / Semeraro, N. / Nenci, G.G. / Colucci, M. et al. | 1994
- 90
-
Lipoprotein(a) levels and fibrinolytic activity in patients with nephrotic syndromeM.D. Sae Yong Hong / M.D. Dong Ho Yang et al. | 1994
- 90
-
D-dimer XDP correlate with fibrinolytic shutdown in renal transplant patients treated with anti-T-cell antibodiesChen, J.P. / McGrath, G. / Spears, A. / Koella, L. / Kirby, C. / Goldman, M.H. et al. | 1994
- 90
-
Depression of fibrinolysis in peritoneum during surgery is a local response to traumaHolmdahl, L. / Eriksson, E. / Risberg, B. et al. | 1994
- 91
-
Low levels of lipoprotein (A) do not influence hyperfibrinolysis in patients with liver cirrhosisAlessandri, C. / Basili, S. / Ferro, D. / Quintarelli, C. / Cordova, C. / Violi, F. et al. | 1994
- 91
-
Will a decrease of blood homocysteine by vitamin supplementation reduce the risk for vascular disease?den Heijer, M. / Bos, G.M.J. / Gerrits, W.B.J. / Blom, H.J. et al. | 1994
- 91
-
Impaired fibrinolytic capacity in women with early recurrent unexplained miscarriages: a low-molecular-weight heparin (enoxaparin) favours successful pregnancyGris, J.C. / Schved, J.F. / Neveu, S. / Tailland, M.L. / Marès, P. et al. | 1994
- 91
-
Inflammatory mediators and hyperfibrinolysis in orthotopic liver transplantationPáramo, J.A. / Prósper, F. / Rifón, J. / Hermida, J. / Panizo, C. / Rocha, E. et al. | 1994
- 92
-
The receptor for urokinase plasminogen activator is resent in both the ligand-binding and the cleaved form in ductal breast carcinomaHøyer-Hansen, G. / Solberg, H. / Rønne, E. / Brünner, N. / Nielsen, B.S. / Rank, F. / Timshel, S. / Kragh, C. / Danø, K. et al. | 1994
- 92
-
Modulation of tumor growth and angiogenesis by PAI-1Kwaan, H.C. / Verrusio, E. / Yoshida, E. / Soff, G.A. et al. | 1994
- 92
-
uPA and PAI-1 predict survival in advanced ovarian cancer patientsKuhn, W. / Schmitt, M. / Pache, L. / Schmalfeldt, B. / Dettmar, P. / Jänicke, F. / Graeff, H. et al. | 1994
- 93
-
A genetic conjugate between human albumin and amino terminal fragment of urokinase: A promising agent in anticancer therapyLu, H. / Yeh, P. / Guitton, D. / Mabilat, C. / Mirshahi, S.S / Pouchelet, M. / Burtin, P. / Soria, J. / Soria, C. et al. | 1994
- 93
-
A comparative study of latex d-dimer reagentsVan der Planken, M. / Vertessen, F. / Aharchi, F. / Peetermans, M. et al. | 1994
- 93
-
Changes in fibrinolysis and clotting parameters in acute promyelocytic leukemia (APL) patients treated with al-transretinoic acid (ATRA)Falanga, A. / Iacoviello, L. / Belotti, D. / D'Orazio, A. / Consonni, R. / Marziali, S / Barbui, T. / Donati, M.B. et al. | 1994
- 93
-
Urokinase-type plasminogen activator and its receptor in extracellular matrix degradation by melanoma cell lines in vitroOuax, P.H.A. / de Bart, A.C.W. / Janson, A.F. / van Muijen, G.N.P. / Weidle, U. / Verheijen, J.H. et al. | 1994
- 94
-
Streptokinase stimulates thrombin generation independent of its fibrinolytic effect via plasminogenMeiier, P. / Kluft, C. / Brommer, E.J.P. et al. | 1994
- 94
-
Partial purification and properties of a thrombin activated fibrinolysis inhibitor (TAFI)Bajzar, L. / Nesheim, M.E. et al. | 1994
- 94
-
Requirement of Zn2+ for binding of histidine-rich glycoprotein to PVC-adsorbed fibrinogen and fibrinvan Boheemen, P.A. / Slappendel, S.L.G. / Hennis, B.C. / Dooijewaard, G. / Kluft, C. et al. | 1994
- 95
-
Abnormal fibrins defective in the exposure of sites involved in the acceleration of t-PA mediated plasminogen activationNieuwenhuizen, W. / Voskuilen, M. / Matsuda, M. / Haverkate, F. / Koopman, J. / Briët, E. / Janzarik, H. et al. | 1994
- 95
-
Plasmic degradation of fibrin rapidly decreases platelet adhesion and spreadingHamaguchi, M. / Bunce, L.A. / Sporn, L.A. / Francis, C.W. et al. | 1994
- 95
-
Attenuated cross-linked fibrin degradation in patients treated with streptokinase and intravenous heparinGalvani, M. / Abendschein, D. / Ferrini, D. / Ottani, F. / Rusticali, F. / Eisenberg, P. et al. | 1994
- 96
-
Sorting of tissue plasminogen activator (tPA) into the regulated secretory pathwayLevin, E.G. / Marotti, K. / Santell, L. et al. | 1994
- 96
-
The specificity and sensitivity of latex and ELISA methods for fibrin degradation products in the diagnosis of myocardial infarctionDouglas, J.T. / Shaukat, N. / Bennett, J.L. / Cotter, L. / Rowlands, D.J. et al. | 1994
- 96
-
Independence of circadian rhythm of endogenous cortisol production and diurnal fluctuations of fibrinolysis in hospitalized patientsSie, P. / Caron, Ph. / Boneu, B. et al. | 1993
- 96
-
A unique response of human cerebral microvascular endothelial cells to α-thrombinShatos, M.A. / Orfeo, T. / Doherty, J.M. / Penar, P.L. / Collen, D.J. / Mann, K.G. et al. | 1994
- 96
-
The tyrosine protein kinase inhibitor genistein reduces tnfa-induced plasminogen activator inhibitor-1 transcription in endothelial cellsvan Hinsbergh, Victor W.M. / Vermeer, Mario / Koolwijk, Pieter / Grimbergen, Jos / Kooistra, Teaice et al. | 1994
- 97
-
Ligand-dependent co-capping of uPA receptor with intracellular tyrosine-phosphorylated proteinsGuttinger, M. / Resnati, M. / Valcamonica, S. / Blasi, F. / Fazioli, F. et al. | 1994
- 97
-
Plasmin as a previously unknown powerful inducer of the endothelium-dependent vasodilatationSergeev, I.Y. / Bashkov, G.V. et al. | 1994
- 97
-
Signal transduction via the urokinase receptor is dependent on both ligand binding and clustering of the receptor in human tumour cell linesRuthner, M. / Binder, B.R. et al. | 1994
- 98
-
Thrombolytic therapy in acute stroke: An updateHacke, W. et al. | 1994
- 99
-
“Dethrombosis”: Erosion ratiier than lysisMcBane, R.D. / Wysokinski, W.E. / Stewart, M.L. / Owen, W.G. et al. | 1994
- 99
-
Restenosis after balloon-expandable stent for femoral artery stenosis reduced by target application of low molecular-weight heparinJørgensen, B. / Larzon, T. / Ragnarsson, A. / Johnsson, K.-Å. / Stenberg, B. / Arfvidsson, B. / Eliasson, K. / Nielsen, J.D. et al. | 1994
- 99
-
Quantitative immunological determination of human fibrin- and fibrinogen-degradation products (FDP) in plasma with an antibody against a synthetic peptideKraus, M. / Aillaud, E. / Stüber, W. et al. | 1994
- 99
-
Local thrombolysis for occluded arterial grafts: Is the yield worth the effort?Lacroix, H. / Nevelsteen, A. / Stockx, L. / Wilms, G. / Verhaeghe, R. et al. | 1994
- 100
-
A pilot study on thrombolysis with recombinant staphylokinase (star) in patients with peripheral arterial occlusionVanderschueren, S. / Wilms, G. / Stockx, L. / Verhaeghe, R. / Vermylen, J. / Collen, D. et al. | 1994
- 100
-
Results of the pro-urokinase (PRO-UK) and tissue plasminogen activator (t-PA) enhancement of thrombolysis (patent) trialGurewich, V. / PATENT Investigators et al. | 1994
- 100
-
An accelerated “frontloaded” RT-PA thrombolysis regimen achives higher TIMI III patency rates in acute myocardial infarctionGulba, D.C. / Dechend, R. / Hauck, S. / Osterziel, K.-J. / Barthels, M. / Lichtlen, P.R. / Dietz, R. et al. | 1994
- 101
-
Arterial neointima formation after trauma in mice with inactivation of the t-PA, u-PA or PAI-1 genesCarmeliet, P. / Stassen, J.M. / De Mol, M. / Declercq, C. / Bouché, A. / Collen, D. et al. | 1994
- 101
-
Stability of tetranectin concentration in blood samplesHøgdall, C.K. et al. | 1993
- 101
-
Adenovirus-mediated gene transfer of rt-PA restores thrombolysis in t-PA deficient miceCarmeliet, P. / Stassen, J.M. / Collen, D. / Meidell, R.S. / Gerard, R. et al. | 1994
- 101
-
Regulation of the fibrinolytic system during gonadotropin-induced ovulation in mice with inactivation of the genes encoding tPA, uPA or PAI-iPeng., X-R. / Leonardsson, G. / Carmeliet, P. / Mulligan, R. / Collen, D. / Ny, T. et al. | 1994
- 102
-
Fragmentation pattern of fibrinogen during thrombolysis in acute myocardial infarction with fibrin-specific plasminogen activators — Detection of high-molecular weight fibrinogen degradation productsDechend, R. / Thode, H. / Müller, T. / Eisert, W.E. / Dietz, R. / Gulba, D.C. et al. | 1994
- 102
-
Reduced pulmonary metastases of lewis lung carcinoma in hPAI-1 transgenic micePoggi, A. / Bellelli, E. / Salvatore, L. / Castelli, M.P. / Marinacci, R. / Rella, C. / Iacoviello, L. / Erickson, L.A. / Bini, A. / Donati, M.B. et al. | 1994
- 102
-
Fibrinogen-deficient transgenic miceDegen, Jay L. / Jensen, Nancy J. / Daugherty, Cynthia C. / McLain, Kersten / Steven Potter, S. / Suhl, Theodore T. et al. | 1994
- 102
-
Expression of recombinant human fibrinogen in the milk of transgenic micePrunkard, D. / Garner, I. / Foster, D. et al. | 1994
- 103
-
Analysis of plasminogen activator inhibitor type 1 (PAI-1) by light spectroscopy: attempts to determine intra-molecular distancesAleshkav, S.B. / Fa, M. / Karolin, J. / Strandberg, L. / Johansson, L.B.Å. / Ny, T. et al. | 1994
- 103
-
The interaction of PAI-1 with immobilised vitronectin and the effect of tPA and the protease domain of tpaEhnebom, J. / Björquist, P. / Boström, S. / Deni, J. et al. | 1994
- 103
-
A model of the active form of plasminogen-activator-inhibitor-1Aertgeerts, K. / De Ranter, C. / De Bondt, H.L. / Declerck, P.J. et al. | 1994
- 104
-
The interaction between PAI-1 and vitronectinSigurdardottir, Olöf / Dahlström, Tova / Wiman, Björn et al. | 1994
- 104
-
Evidence for and possible function of a complex between (latent) PAI-1 and prourokinase (pro-UK)Liu, J. / Gurewich, V. et al. | 1994
- 104
-
PAI-1 released from cultured human endothelial cells delays fibrinolysis and is incorporated into the developing fibrin clotHandt, S. / Jerome, W.G. / Braaten, J.V. / Lewis, J.C. / Kirkpatrick, C.J. / Hantgan, R.R. et al. | 1993
- 104
-
Immunological characterization of type 1 plasminogen activator inhibitor (PAI-1) binding to native and urea-treated vitronectin (VN)Shaughnessy, S.G. / Podor, T.J. et al. | 1994
- 105
-
Isolation and characterization of plasminogen activator inhibitor 1 (PAI- 1)mutant( e350g, e351k)Hu, M.-H. / Sui, G.-C. et al. | 1994
- 105
-
Kinetics of Interaction of Serine Proteinases with native PAI-1 and its Substrate Variant T333RVerhamme, I.M. / Kvassman, J. / Lawrence, D. / Ginsburg, D. / Shore, J.D. et al. | 1994
- 105
-
D-dieter during intra-arterial low-dose streptokinase treatment of peripheral arterial occlusive diseaseStegnar, M. / Kozak, M. / Šabovič, M. et al. | 1994
- 105
-
The, behavior of plasminogen activatorinhibitor released from activated plateletsDeguchi, D. / Deguchi, I. / Maeda, T. / Wakita, Y. / Wada, H. / Murashima, S. et al. | 1994
- 105
-
D-Dimer During Intra-Arterial Low-Dose Streptokinase Treatment of Peripheral Arterial Occlusive DiseaseStegnar, M. / Kozak, M. / Sabovic, M. et al. | 1994
- 106
-
Alternative targeting of a serpin-type inhibitor by glycosaminoglycans (GAGs): Heparin binding of protein C inhibitor (pci) prevents its interaction with tissue kallikrein (tk)Ecke, S. / Geiger, M. / Binder, B.R. et al. | 1994
- 106
-
Investigations of thrombin inhibitors in fibrinolytic systemsRarabas, E. / Bagdy, O. / Bajusz, S. / Széll, E. et al. | 1994
- 106
-
Fibrin(ogen) binding region in urinary protein c inhibitorHayashi, S. / Wakizaka, A. et al. | 1994
- 107
-
Interaction of tissue plasminogen activator with c1-inhibitorPinches, Stuart A. / Moore, Norma R. / Booth, Nuala A. et al. | 1994
- 107
-
Expression of the alpha 2-antiplasmin gene in adult murine tissuesMenoud, P.A. / Khoshbeen, M. / Sappino, N. / Vassalli, J.D. / Sappino, A.P. et al. | 1994
- 108
-
Systemic fibrinolytic effect of pulse spray thrombolysis with tissue-type plasminogen activator (rt-PA)Yusuf, S.W. / Westby, J. / Wenham, P.W. / Hopkinson, B.R. / Makin, G.S. et al. | 1994
- 108
-
Polymerized fibrin enhances the conversion of lys-plasminogen to lys-plasmin by single chain tPA more effectively than by its two chain formUrano, T. / Ihara, H. / Takada, Y. / Takada, A. et al. | 1994
- 108
-
Computer simulation of dynamic spatial concentrations within dissolving fibrin: Implications for drug design and deliveryDiamond, S.L. / Anand, S. et al. | 1994
- 108
-
The interactions of tissue-type plasminogen activator with fibrinPaoni, N.F. / Keyt, B.A. / Jones, A.J.S. / Refno, C.J. / Botstein, D. / Bennett, W.F. et al. | 1994
- 109
-
Effect of lipoprotein (a) on the activation of fibrinolytic systemNordenhem, A. / Haegerstrand-Björkman, M. / Wiman, B. et al. | 1994
- 109
-
Conformationally changed fibrinogen (fg) stimulates the tissue plasminogen activator (t-PA)catalysed conversion of plasminogen to plasminHaddeland, U. / Brosstad, F. et al. | 1994
- 109
-
Effects of heparan sulfate analogue or other sulfated polysaccharides on the activation of plasminogen by activatorsTakada, Y. / Urano, T. / Ihara, H. / Takada, A. et al. | 1994
- 110
-
Multiple binding with identical linkage: a mechanism that explains the effect of lp(a) on fibrinolysisHervio, L. / Girard, A. / Durlach, V. / Anglés-Cano, E. et al. | 1994
- 110
-
Euglobulin and plasma clot lysis in subjects with elevated lipoprotein(a)Stegnar, M. / Ambroz̆ic̆, J. / Berger, B. / Keber, I. et al. | 1994
- 110
-
Addition of plasminogen enhances the lysis of ex vivo thrombi in ex-vivo plasmaŠabovič, M. et al. | 1994
- 111
-
Anti-aggregatory activity of recombinant single-chain urokinase-type plasminogen activatorRomanova, E.P. / Gorbunova, N.A. / Jitkova, J.V. / Bashkov, G.V. et al. | 1994
- 111
-
Plasmin-catalyzed degradation of noncrosslinked fibrin in a perfused clotWalker, J. / Nesheim, M.E. et al. | 1994
- 111
-
Planar and finger-like lysing patterns of blood clotsZidanšek, A. / Blinc, A. / Lahajnar, G. / Keber, D. / Blinc, R. et al. | 1994
- 111
-
The role of PAI-1 in the lysis of platelet rich clotsHulander, M. / Matisson, C. / Boström, S. et al. | 1994
- 112
-
The amount of acutely releasable tissuetype plasminogen activator (tPA) closely correlates with the rate of constitutive tPA secretionSchrauwen, Y. / de Vries, R.E.M. / Kooistra, T. / Emeis, J.J. et al. | 1994
- 112
-
Effect of platelet on clot lysis by urokinase-type plasminogen activatoerYuasa, H. / Okada, K. / Matsuo, O. et al. | 1994
- 112
-
Increasing the fibrin specificity of t-PA enhances its activity towards platelet rich clotsRefino, Canio J. / Badillo, Julie M. / Paoni, Nicholas F. / Ket, Bruce A. / Nguyen, Hung V. / Bennett, William F. et al. | 1994
- 113
-
Localization and characterization of a retinoic acid response-like element in the plasminogen activator inhibitor-2 gene promoterSchuster, W.A. / Medcalf, R.L. / Kruithof, E.K.O. et al. | 1993
- 113
-
Plasmin-induced endothelium-dependent vasodilatation versus fibrinolysis — Two pathways of blood flow restoration in the thrombotically occluded vessels?Mashina, S.Y. / Bashkov, G.V. et al. | 1994
- 113
-
The broad variability of plasma pro-urokinase (Pro-UK) tolerance and two of its determinants in plasmaPannell, R. / Gurewich, V. et al. | 1994
- 113
-
Release of PAI-1 from the vessel wall is affected by mechanical traumaFalkenberg, M. / Eriksson, E. / Ötenwall, P. / Risberq, B. et al. | 1994
- 113
-
Isolation of a rat vitronectin cdna clone from a hepatocyte cdna libraryOtter, M. / Kuiper, J. / Riiken, D.C. / van Zonneveld, A.-J. et al. | 1994
- 114
-
Cytosolic phospholipase a2 activity in resting and tnf-stimulated cultured human endothelial cellsPeiretti, F. / Alessi, M.C. / Chomiki, N. / Delézay, M. / Juhan-Vague, I. / Nalbone, G. et al. | 1994
- 114
-
Effects of lipopolysaccharide on the expression of fibrinolytic factors in an established cell line from human endothelial cells (t-hue2)Matsumoto, H. / Fukao, H. / Hagiya, Y. / Nonaka, T. / Okada, K. / Ueshima, S. / Mitsui, Y. / Kobayashi, M. / Izaki, S. / Matsuo, O. et al. | 1994
- 114
-
Expression of t-PA, u-PA, PAI-1 and PAI-2 in cultured human endothelial cells in response to endotoxin, tumor necrosis factor-a, interleukin-6 and interferon-γArnman, V. / MD.,PhD Stemme, S. / MD,PhD Rymo, L. / MD.,PhD Risberg, B et al. | 1994
- 115
-
Activation and inhibition of the fibrinolytic system in cancer patients after isolated limb perfusion with tumor necrosis factor a, (interferon γ) and melphalanBom, V.J.J. / Zwaveling, J.H. / Girbes, A.R.J. / van Ginkel, R.J. / Koops, H.Schraffordt / van der Meer, J. et al. | 1994
- 115
-
Thrombin-induced modulation of mast cells activityStrukova, S.M. / Khlgatian, S.V. / Duglna, T.N. / Gasanova, N.G. / Matreoshin, A.V. et al. | 1994
- 115
-
Effect of endotoxin, il-1 and i-nf on fibrinolytic activity of endothelial cellsChordd, C. / Páramo, J.A. / Montes, R. / Orbe, I. / Rocha, E. et al. | 1994
- 116
-
An Experimental System for Investigation of Penetration of Components of the Fibrinolytic System to a Plasma ClotSakharov, D. V. / Domogatsky, S. P. / Bos, R. / Rijken, D. C. et al. | 1994
- 116
-
Arterial shear stress induces synthesis and nuclear localization of c-fos in cultured human endothelial cellsRanjan, V. / Diamond, S.L. et al. | 1994
- 116
-
An experimental system for investigation of penetration of components of the fibrinolytic system into a plasma clotSakharov, D.V. / Domogatsky, S.P. / Bos, R. / Rijken, D.C. et al. | 1994
- 116
-
Plasmin induces tissue factor expression in monocytes: possible interim between cellassociated fibrinolysis and the extrinsic pathway of coagulationKurabekova, R.M. / Bashkov, G.V. et al. | 1994
- 116
-
Plasminogen activators as growth factorsof human fibroblastsDe Petro, G. / Copeta, A. / Barlati, S. et al. | 1994
- 117
-
Effects of vasoconstrictors and insulin on synthesis and release of t-PA and PAI-1 from human umbilical vein endothelial cellsSelieflot, Ingebjørg / Kähler, Hanne / Amesen, Harald / Lyberg, Torstein et al. | 1994
- 117
-
Quantitative and qualitative differences in the production of t-PA and PAI-1 from human umbilical (huvec) vs. human adult vein endothelial cells (havec).Rydholm, H. / Boström, S / Eriksson, E. / Risberg, B. et al. | 1994
- 117
-
Supersulfated lmw heparin modulation of t-PA and PAI-1 release from human umbilical vein endothelial cells in cultureKlöcking, H.-P. / Heller, B. et al. | 1994
- 118
-
Acute t-PA and PAI-1 release by gl-522(Y- 1)Kurtze, U. / Åstedt, B. / Fareed, J / Klöcking, H.-P. et al. | 1994
- 118
-
Differential effect of stereospecific analogues of nucleoside cyclic 3',5'phosphorus on the release of PAI-1 from human endothelial cellsCierniewski, C.S. / Swiatkowska, M. / Krzeslowska, J. / Laudanski, T. / Baraniak, J. / Stec, W.J. et al. | 1994
- 118
-
Direct suppression of the synthesis of plasminogen activator inhibitor 1 (PAI-1) by gemfibrozil in primary hepatocyte cultures and hep g2 cellsArts, J. / Kaptein, A. / Princen, H.M.G. / Kooistra, T. et al. | 1994
- 119
-
Notoginsenoside R1 counteracts the induction of plasminogen activator inhibitor-1 and tissue factor in response to endotoxin stimulation in vitro and in vivoZhang, W.J. / Woita, J.I. / Binder, B.R.I. et al. | 1994
- 119
-
Mechanisms involved in the increased expression of PAI-1 in hepg2 cells treated with very low density lipoproteinsMussoni, L. / Banfi, C. / Sironi, L. / Baldassarre, D. / Prati, L. / Tremoli, E. et al. | 1994
- 119
-
The role of activator protein-1 (ap-1) in the protein kinase c (pkc)-mediated expression of plasminogen activator inhibitor i (PAI-1) in hep g2 cellsArts, J. / Grimbergen, J. / Bosma, P. / Kooistra, T. et al. | 1994
- 120
-
Stimulation of monocytes with thrombin causes increased plasminogen activator inhibitor 2 (PAI-2) synthesisRitchie, Helen M. / Jamieson, Alec / Booth, Nuala A. et al. | 1994
- 120
-
Long-term influence of omega-3 fatty acids on fibrinolysis, fibrinogen, and serum lipidsEritsland, J. / Seljeflot, I. / Abdelnoor, M. / Arnesen, H. et al. | 1993
- 120
-
Reduction of PAI-2 in human monocytes by estradiol and progesteroneKinnby, B. / Åstedt, B. / Casslén, B. et al. | 1994
- 120
-
Regulation of PAI-1 mrna stability in rat hepatoma cellsHeaton, J.H. / Leff, N.S. / Gelehrter, T.D. et al. | 1994
- 120
-
Fibrin turnover in plasma and peritoneal dialysis effluent of capd patients with and without peritonitisGoedde, M. / Sitter, T. / Hoffmann, H. / Schramm, W. / Spannagl, M. et al. | 1994
- 121
-
Vitronectin gene expression in vivo: Evidence for extrahepatic synthesis and acute phase regulationSeiffert, D. / Crain, K. / Wagner, N.V. / Loskutoff, D.J. et al. | 1994
- 121
-
Plasminogen activator inhibitor type 2 partly protects against tumor necrosis factor (TNF)-mediated cytolysisMikus, P. / Ny, T. et al. | 1994
- 122
-
Bio-immuno assay for tissue-type plasminogen activator (t-PA) in (stabilyte®) plasmaBos, R. / Revet, M. / Nieuwenhuizen, W. et al. | 1994
- 122
-
Influence of endogenous SCU-PA in t-PA determinations using coaset t-PA and spectrolyse®/fibrin. comparison with coatest BIA t-PAWejkum, L. / Ersdal Badiu, E. / Rosén, S. et al. | 1994
- 122
-
Activation of coagulation and fibrinolysis in acute or chronic coronary artery diseaseAndreotti, F. / Lefroy, D.C. / Offeringa, L. / Crake, T. / Maseri, A. / Kluft, C. / the BEST Investigators et al. | 1994
- 122
-
Measurement of tPA antigen: Comparison of tintelize® and imubind® methodsStroop, D.M. / Glueck, C.J. / Glueck, H.I. / Hamer, T. / Tracy, T. / Schumacher, H.R. et al. | 1994
- 123
-
Urokinase-type receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodiesGrøndahl-Hansen, J. / Brünner, N. / Clark, G.M. / Danø, K. / Høyer-Hansen, G. / Osborne, C.K. / Pedersen, H. / Rank, F. / Rønne, E. et al. | 1994
- 123
-
An Elisa assay for quantification of complex in human plasmaMontes, R. / Páramo, J.A. / Chordd, C. / Orbe, J. / Rocha, E. et al. | 1994
- 124
-
Baseline levels of α 2-antiplasmin-plasmin complex in human plasmaMeijer, P. / Kamerling, S.W.A. / van de Ham, F.J. / Kret, R. / Kluft, C. / Kraus, J. / Wagner, C. et al. | 1994
- 124
-
First experience with a new assay for activity determination of protein SWagner, C. / Girolami, A. / Simeoni, P. / Dati, F. et al. | 1994
- 124
-
A quantitative immunoassay for the lysine binding function of lipoprotein(a) in plasmaHoover-Plow, J. / Skocir, P. / Hinman, J. / Fless, G.M. / Scanu, A.M. / Plow, E.F. et al. | 1994
- 124
-
Aprotinin at therapeutic dose levels affects chromogenic substrate assays for fibrinolytic parameters and protein CWendel, H.P. / Gallimore, M.L. / Heller, W. et al. | 1994
- 125
-
Correlations between stimulated and basal values of t-PA and the serum d-dimer testSeljeflot, Ingebjørg / Eritsland, Jan / Andersen, Per / Arnesen, Harald et al. | 1994
- 125
-
Measurement of D-dimer: Evaluation of dimertesto® and asserachromo® EIA with D-di test® and Thrombo-Wellcotesto® latex methodsStroop, D.M. / Kuchle, D.A. / Glueck, H.I. / Schumacher, H.R. et al. | 1994
- 125
-
Detection of soluble fibrin by enzyme immunoassayDinh, D. / Bolitho, J. / Bundesen, P. / Hillyard, C. / Marsh, N. / Moore, B. / Bottenus, R. / Rylatt, D. et al. | 1994
- 126
-
Thrombolytic properties of an immunoconjugate between single-chain urokinase-type plasminogen activator (scu-PA) and F(ab′)2 of bispecific monoclonal antibody against fibrin and against u-PA in hamstersKurokawa, T. / Watanabe, A. / Kakinuma, A. / Iwasa, S. et al. | 1993
- 126
-
Thrombolytic Properties of an Immunoconjugate Between Single-chain Urokinase-type Plasminogen Activator (u-PA) and F(ab^1)~2 of Bispecific Monoclonal Antibody Against Fibrin and Against u-PA in HamstersKurokawa, T. / Watanabe, A. / Kakinuma, A. / Iwasa, S. et al. | 1994
- 126
-
Influence of venous occlusion on the results of an activated microtitre clot lysis assay in plasma from individuals with and without a history of venous thrombosisKuhnt, R. / Mondorf, W. / Reitz, H. / Schoeppach, H. / Stoll, H. / Zwinge, B. / Scharrer, I. et al. | 1994
- 126
-
Plasmin-antiplasmin complexes in prognostic evaluation of patients with unstable anginaBiasucci, L.M. / Liuzzo, G. / Monaco, C. / Quaranta, G. / Caligiuri, G. / Rebuzzi, A.G. / van de Greef, W. / Maseri, A. / Kluft, C. et al. | 1994
- 126
-
A spectroscopic microtiter fibrin plate assaySidelmann, J. / Jespersen, J. / Gram, J. et al. | 1994
- 126
-
Vidas D-dimer, a new immunoenzymatic assay for fibrin degradation products (fbDP)Reber, G. / Minazio, P. / Bounameaux, H. / De Moerloose, P. / Durand, C. / Dupuy, G. / Pittet, J.L. et al. | 1994
- 127
-
Influence of the plasma concentration of plasminogen activator inhibitor, plasminogen, fibrinogen and streptokinase antibodies on results of an activated mictrotitre clotlysis assayReitz, H. / Mondorf, W. / Kuhnt, R. / Schoeppach, H. / Stoll, H. / Zwinge, B. / Scharrer, I. et al. | 1994
- 127
-
An in vitro model for a human thrombus II: Kinetic analysis of lysis of an aged thrombusHandt, S. / Jerome, W.G. / Lewis, J.C. / Dekker, A. / Kirkpatrick, C.J. / Hantgan, R.R. et al. | 1994
- 127
-
An in vitro model for a human thrombus I: Characterization of the modelJerome, W.G. / Handt, S. / Dekker, A. / Kirkpatrick, C.J. / Lewis, J.C. / Hantgan, R.R. et al. | 1994
- 128
-
Development of an assay for cellular fibrinolysisBuckham, S. / Humphray, H. et al. | 1994
- 128
-
Increased plasmin generation and activity in hiv-infected patients: In vivo rather than in vitro activation of the fibrinolytic systemToulon, P. / Gris, J.C. / Candia, N. / Demay, Y. / Sereni, D. / Sicard, D. / Schved, J.F. et al. | 1994
- 128
-
Production of 35-S labelled and active recombinant PAI-1Rubio, N. / Martin-Satue, M. / Marrugat, R. / Felez, J. / Blanco, J. et al. | 1994
- 128
-
In vitro clot lysis: a comparative study of three methodsArocha-Piñango, C.L. / Lopez, M. / Ojeda, A. et al. | 1994
- 129
-
Alprostadil (prostaglandin E1): A double blind study in patients with peripheral arterial occlusive diseaseBennett, J.L. / Liderth, S.A. / Welch, M. / Smyth, V.J. / Walker, M.G. / Douglas, J.T. et al. | 1994
- 129
-
The influence of angiographic x-ray contrast substances on the clotting system of patients with arterial occlusionHeller, W. / Wendel, H.P. / Bäuerle, C. et al. | 1994
- 129
-
High thrombin-antithrombin III and prothrombin fragment F1+2 plasma levels in loco-regional thrombolytic therapy of peripheral arterial thrombosisAvello, G. / Avello, A.G. / Frade, L.J. / Cancelas, J.A. / Gandarias, C. / Ocaña, J. / Lasso, M. et al. | 1994
- 130
-
How does heparin enhance thrombolysis?Dechend, R. / Hauck, S. / Osteaziel, K.-J. / Gödecke, W. / Praus, M. / Barthels, M. / Dietz, R. / Gulba, D.C. et al. | 1994
- 130
-
Plasma levels of molecular markers in patients with venous thrombosisDanchev, D. / Stancheva, A. / Magaev, B. et al. | 1994
- 130
-
Haemostatic activation parameters in acute myocardial infarctionStancheva, A. / Danchev, D. et al. | 1994
- 131
-
Plasminogen activator inhibitor in plasma and platelets of patients with thrombocythemiaSartori, M.T. / Randi, M.L. / Zerbinati, P. / Saggiorato, G. / Theodoridis, P. / Girolami, A. / Patrassi, G.M. et al. | 1994
- 131
-
Does diabetes mellitus affect the fibrinolytic and thrombotic agent-induced alterations in structural and dynamic parameters of platelet membranes?Watala, C. / Gwozdzinski, K. / Pietrucha, T. / Cierniewski, C.S. et al. | 1994
- 131
-
The role of nitric oxide synthase inhibition in the platelet functionBodzenta-Łukaszyk, A. / Łukaszyk, A. / Gabrvelewicz, A. / Bielawiec, M. / Konturek, S. et al. | 1994
- 132
-
Factor VII coagulant activity is related to blood lipids in the elderly. The Rotterdam studyvan der Bom, J.G. / Bots, M.L. / van Vliet, H.H.D.M. / Hofman, A. / Grobbee, D.E. et al. | 1994
- 132
-
Vascular and platelet adhesion molecijles: E-selectin, ICAM-1, VCAM-1, GMP-140 and platelet derived growth factor in diabetesDouglas, J.T. / Bennett, J.L. / Young, M.J. / Boulton, A.J.M. et al. | 1994
- 132
-
Fibrinolysis, platelet function and serotonin in diabetes: A possible link?Malyszko, J. / Taminato, T. / Urano, T. / Ihara, H. / Takada, Y. / Takada, A. et al. | 1994
- 132
-
Comparison of the hemostatic risk factors between coronary artery disease and diabetes in ChineseHo, C.H. / Wang, S.P. / Jap, T.S. et al. | 1994
- 133
-
Effect of niceritrol on coagulation and fibrinolytic systems in patientts with hypercholesterolemiaWada, H. / Mori, Y. / Wakita, Y. / Minamikawa, K. / Nagaya, S. / Deguchi, K. / Shirakawa, S. et al. | 1994